{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:10:19Z","timestamp":1791256219531,"version":"4.1.0"},"reference-count":292,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100020582","name":"National Institute of Pharmaceutical Education and Research, Raebareli","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/RLF\/Re-Entry\/40\/2021"],"award-info":[{"award-number":["BT\/RLF\/Re-Entry\/40\/2021"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microchim Acta"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00604-025-07505-2","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T05:40:08Z","timestamp":1758692408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Micro- and nanoscale biosensing technologies for early diagnosis of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"192","author":[{"given":"Tejas","family":"Nikam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhini A.","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"7505_CR1","doi-asserted-by":"publisher","first-page":"a028035","DOI":"10.1101\/cshperspect.a028035","volume":"9","author":"BN Dugger","year":"2017","unstructured":"Dugger BN, Dickson DW (2017) Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol 9:a028035. https:\/\/doi.org\/10.1101\/cshperspect.a028035","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"7505_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20:385\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2","journal-title":"Lancet Neurol"},{"key":"7505_CR3","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1503\/cmaj.151179","volume":"188","author":"P Rizek","year":"2016","unstructured":"Rizek P, Kumar N, Jog MS (2016) An update on the diagnosis and treatment of Parkinson disease. CMAJ 188:1157\u20131165. https:\/\/doi.org\/10.1503\/cmaj.151179","journal-title":"CMAJ"},{"key":"7505_CR4","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.1007\/s12035-021-02500-z","volume":"58","author":"Y Gopar-Cuevas","year":"2021","unstructured":"Gopar-Cuevas Y, Duarte-Jurado AP, Diaz-Perez RN et al (2021) Pursuing multiple biomarkers for early idiopathic Parkinson\u2019s disease diagnosis. Mol Neurobiol 58:5517\u20135532. https:\/\/doi.org\/10.1007\/s12035-021-02500-z","journal-title":"Mol Neurobiol"},{"key":"7505_CR5","doi-asserted-by":"publisher","first-page":"101834","DOI":"10.1016\/j.arr.2022.101834","volume":"84","author":"ABR Leite Silva","year":"2023","unstructured":"Leite Silva ABR, Gon\u00e7alves De Oliveira RW, Di\u00f3genes GP et al (2023) Premotor, nonmotor and motor symptoms of Parkinson\u2019s disease: a new clinical state of the art. Ageing Res Rev 84:101834. https:\/\/doi.org\/10.1016\/j.arr.2022.101834","journal-title":"Ageing Res Rev"},{"key":"7505_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","volume":"17","author":"D Berg","year":"2021","unstructured":"Berg D, Borghammer P, Fereshtehnejad S-M et al (2021) Prodromal Parkinson disease subtypes \u2014 key to understanding heterogeneity. Nat Rev Neurol 17:349\u2013361. https:\/\/doi.org\/10.1038\/s41582-021-00486-9","journal-title":"Nat Rev Neurol"},{"key":"7505_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:435\u2013450. https:\/\/doi.org\/10.1038\/nrn.2017.62","journal-title":"Nat Rev Neurosci"},{"key":"7505_CR8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","volume":"86","author":"G Rizzo","year":"2016","unstructured":"Rizzo G, Copetti M, Arcuti S et al (2016) Accuracy of clinical diagnosis of Parkinson disease. Neurology 86:566\u2013576. https:\/\/doi.org\/10.1212\/WNL.0000000000002350","journal-title":"Neurology"},{"key":"7505_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/diseases11030089","volume":"11","author":"K Ramakrishna","year":"2023","unstructured":"Ramakrishna K, Nalla LV, Naresh D et al (2023) WNT-\u03b2 catenin signaling as a potential therapeutic target for neurodegenerative diseases: current status and future perspective. Dis 11:89. https:\/\/doi.org\/10.3390\/diseases11030089","journal-title":"Dis"},{"key":"7505_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni T, Chahine LM, Poston K et al (2024) A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research. Lancet Neurol 23:178\u2013190. https:\/\/doi.org\/10.1016\/S1474-4422(23)00405-2","journal-title":"Lancet Neurol"},{"key":"7505_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/mds.27360","volume":"33","author":"AE Lang","year":"2018","unstructured":"Lang AE, Espay AJ (2018) Disease modification in Parkinson\u2019s disease: current approaches, challenges, and future considerations. Mov Disord 33:660\u2013677. https:\/\/doi.org\/10.1002\/mds.27360","journal-title":"Mov Disord"},{"key":"7505_CR12","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1021\/acschembio.4c00365","volume":"19","author":"SP Patel","year":"2024","unstructured":"Patel SP, Nikam T, Sreepathi B et al (2024) Unraveling the molecular jam: how crowding shapes protein aggregation in neurodegenerative disorders. ACS Chem Biol 19:2118\u20132130. https:\/\/doi.org\/10.1021\/acschembio.4c00365","journal-title":"ACS Chem Biol"},{"key":"7505_CR13","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet"},{"key":"7505_CR14","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","volume":"25","author":"ML Choi","year":"2022","unstructured":"Choi ML, Chappard A, Singh BP et al (2022) Pathological structural conversion of \u03b1-synuclein at the mitochondria induces neuronal toxicity. Nat Neurosci 25:1134\u20131148. https:\/\/doi.org\/10.1038\/s41593-022-01140-3","journal-title":"Nat Neurosci"},{"key":"7505_CR15","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/mds.26562","volume":"31","author":"T Moors","year":"2016","unstructured":"Moors T, Paciotti S, Chiasserini D et al (2016) Lysosomal dysfunction and \u03b1-synuclein aggregation in Parkinson\u2019s disease: diagnostic links. Mov Disord 31:791\u2013801. https:\/\/doi.org\/10.1002\/mds.26562","journal-title":"Mov Disord"},{"key":"7505_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","volume":"18","author":"L Parnetti","year":"2019","unstructured":"Parnetti L, Gaetani L, Eusebi P et al (2019) CSF and blood biomarkers for Parkinson\u2019s disease. Lancet Neurol 18:573\u2013586. https:\/\/doi.org\/10.1016\/S1474-4422(19)30024-9","journal-title":"Lancet Neurol"},{"key":"7505_CR17","doi-asserted-by":"publisher","first-page":"e13522","DOI":"10.1111\/acel.13522","volume":"20","author":"H Tu","year":"2021","unstructured":"Tu H, Yuan B, Hou X et al (2021) \u03b1-Synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson\u2019s disease. Aging Cell 20:e13522. https:\/\/doi.org\/10.1111\/acel.13522","journal-title":"Aging Cell"},{"key":"7505_CR18","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1093\/brain\/awac313","volume":"145","author":"D Imberechts","year":"2022","unstructured":"Imberechts D, Kinnart I, Wauters F et al (2022) DJ-1 is an essential downstream mediator in PINK1\/parkin-dependent mitophagy. Brain 145:4368\u20134384. https:\/\/doi.org\/10.1093\/brain\/awac313","journal-title":"Brain"},{"key":"7505_CR19","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/mds.27001","volume":"32","author":"M Delgado-Alvarado","year":"2017","unstructured":"Delgado-Alvarado M, Gago B, Gorostidi A et al (2017) Tau\/\u03b1-synuclein ratio and inflammatory proteins in Parkinson\u2019s disease: an exploratory study. Mov Disord 32:1066\u20131073. https:\/\/doi.org\/10.1002\/mds.27001","journal-title":"Mov Disord"},{"key":"7505_CR20","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397:2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"key":"7505_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2741\/S415","volume":"S6","author":"JM Beitz","year":"2014","unstructured":"Beitz JM (2014) Parkinson s disease a review. Front Biosci S6:65\u201374. https:\/\/doi.org\/10.2741\/S415","journal-title":"Front Biosci"},{"key":"7505_CR22","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J (2008) Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368\u2013376. https:\/\/doi.org\/10.1136\/jnnp.2007.131045","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7505_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s10072-019-04165-y","volume":"41","author":"Y Wu","year":"2020","unstructured":"Wu Y, Yao Q, Jiang G-X et al (2020) Identification of distinct blood-based biomarkers in early stage of Parkinson\u2019s disease. Neurol Sci 41:893\u2013901. https:\/\/doi.org\/10.1007\/s10072-019-04165-y","journal-title":"Neurol Sci"},{"key":"7505_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s11658-023-00516-y","volume":"29","author":"J Liang","year":"2024","unstructured":"Liang J, Wan Z, Qian C et al (2024) The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson\u2019s disease. Cell Mol Biol Lett 29:7. https:\/\/doi.org\/10.1186\/s11658-023-00516-y","journal-title":"Cell Mol Biol Lett"},{"key":"7505_CR25","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/cns.13429","volume":"26","author":"M Ugrumov","year":"2020","unstructured":"Ugrumov M (2020) Development of early diagnosis of Parkinson\u2019s disease: illusion or reality? CNS Neurosci Ther 26:997\u20131009. https:\/\/doi.org\/10.1111\/cns.13429","journal-title":"CNS Neurosci Ther"},{"key":"7505_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3233\/JPD-150543","volume":"5","author":"R Melki","year":"2015","unstructured":"Melki R (2015) Role of different alpha-synuclein strains in synucleinopathies, similarities with other neurodegenerative diseases. J Parkinsons Dis 5:217\u2013227. https:\/\/doi.org\/10.3233\/JPD-150543","journal-title":"J Parkinsons Dis"},{"key":"7505_CR27","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/s41467-024-49949-9","volume":"15","author":"A Zarkali","year":"2024","unstructured":"Zarkali A, Thomas GEC, Zetterberg H, Weil RS (2024) Neuroimaging and fluid biomarkers in Parkinson\u2019s disease in an era of targeted interventions. Nat Commun 15:5661. https:\/\/doi.org\/10.1038\/s41467-024-49949-9","journal-title":"Nat Commun"},{"key":"7505_CR28","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323:548. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"key":"7505_CR29","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/mds.22868","volume":"25","author":"KR Chaudhuri","year":"2010","unstructured":"Chaudhuri KR, Prieto-Jurcynska C, Naidu Y et al (2010) The nondeclaration of nonmotor symptoms of Parkinson\u2019s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 25:704\u2013709. https:\/\/doi.org\/10.1002\/mds.22868","journal-title":"Mov Disord"},{"key":"7505_CR30","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH et al (2015) MDS research criteria for prodromal Parkinson\u2019s disease: MDS criteria for prodromal PD. Mov Disord 30:1600\u20131611. https:\/\/doi.org\/10.1002\/mds.26431","journal-title":"Mov Disord"},{"key":"7505_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.smrv.2018.09.008","volume":"43","author":"A Galbiati","year":"2019","unstructured":"Galbiati A, Verga L, Giora E et al (2019) The risk of neurodegeneration in REM sleep behavior disorder: a systematic review and meta-analysis of longitudinal studies. Sleep Med Rev 43:37\u201346. https:\/\/doi.org\/10.1016\/j.smrv.2018.09.008","journal-title":"Sleep Med Rev"},{"key":"7505_CR32","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/jamaneurol.2014.4563","volume":"72","author":"MJ Howell","year":"2015","unstructured":"Howell MJ, Schenck CH (2015) Rapid eye movement sleep behavior disorder and neurodegenerative disease. JAMA Neurol 72:707. https:\/\/doi.org\/10.1001\/jamaneurol.2014.4563","journal-title":"JAMA Neurol"},{"key":"7505_CR33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12264-019-00433-1","volume":"36","author":"T Li","year":"2020","unstructured":"Li T, Le W (2020) Biomarkers for Parkinson\u2019s disease: how good are they? Neurosci Bull 36:183\u2013194. https:\/\/doi.org\/10.1007\/s12264-019-00433-1","journal-title":"Neurosci Bull"},{"key":"7505_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/bcpt.14042","volume":"135","author":"RK Tuominen","year":"2024","unstructured":"Tuominen RK, Renko J (2024) Biomarkers of Parkinson\u2019s disease in perspective of early diagnosis and translation of neurotrophic therapies. Basic Clin Pharmacol Toxicol 135:271\u2013284. https:\/\/doi.org\/10.1111\/bcpt.14042","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"7505_CR35","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/mds.27361","volume":"33","author":"T Simuni","year":"2018","unstructured":"Simuni T, Siderowf A, Lasch S et al (2018) Longitudinal change of clinical and biological measures in early Parkinson\u2019s disease: Parkinson\u2019s progression markers initiative cohort. Mov Disord 33:771\u2013782. https:\/\/doi.org\/10.1002\/mds.27361","journal-title":"Mov Disord"},{"key":"7505_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1212\/WNL.0000000000002651","volume":"87","author":"B Mollenhauer","year":"2016","unstructured":"Mollenhauer B, Zimmermann J, Sixel-D\u00f6ring F et al (2016) Monitoring of 30 marker candidates in early Parkinson disease as progression markers. Neurology 87:168\u2013177. https:\/\/doi.org\/10.1212\/WNL.0000000000002651","journal-title":"Neurology"},{"key":"7505_CR37","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/ene.12444","volume":"21","author":"F Brigo","year":"2014","unstructured":"Brigo F, Matinella A, Erro R, Tinazzi M (2014) [123I] FP - CIT SPECT (Da TSCAN ) may be a useful tool to differentiate between P arkinson\u2019s disease and vascular or drug-induced parkinsonisms: a meta-analysis. Euro J of Neurology 21:1369. https:\/\/doi.org\/10.1111\/ene.12444","journal-title":"Euro J of Neurology"},{"key":"7505_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.33160\/yam.2018.09.001","volume":"61","author":"T Ogawa","year":"2018","unstructured":"Ogawa T, Fujii S, Kuya K et al (2018) Role of neuroimaging on differentiation of Parkinson\u2019s disease and its related diseases. Yonago Acta Med 61:145\u2013155. https:\/\/doi.org\/10.33160\/yam.2018.09.001","journal-title":"Yonago Acta Med"},{"key":"7505_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10286-011-0135-5","volume":"22","author":"G Treglia","year":"2012","unstructured":"Treglia G, Cason E, Stefanelli A et al (2012) MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis. Clin Auton Res 22:43\u201355. https:\/\/doi.org\/10.1007\/s10286-011-0135-5","journal-title":"Clin Auton Res"},{"key":"7505_CR40","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1007\/s00330-020-07240-7","volume":"31","author":"SJ Cho","year":"2021","unstructured":"Cho SJ, Bae YJ, Kim J-M et al (2021) Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson\u2019s disease and factor analysis for its heterogeneity: a systematic review and meta-analysis. Eur Radiol 31:1268\u20131280. https:\/\/doi.org\/10.1007\/s00330-020-07240-7","journal-title":"Eur Radiol"},{"key":"7505_CR41","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.parkreldis.2014.04.005","volume":"20","author":"C Ohtsuka","year":"2014","unstructured":"Ohtsuka C, Sasaki M, Konno K et al (2014) Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging. Parkinsonism Relat Disord 20:755\u2013760. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.04.005","journal-title":"Parkinsonism Relat Disord"},{"key":"7505_CR42","doi-asserted-by":"publisher","first-page":"6503","DOI":"10.21037\/qims-23-87","volume":"13","author":"Q Cao","year":"2023","unstructured":"Cao Q, Han X, Tang D et al (2023) Diagnostic value of combined magnetic resonance imaging techniques in the evaluation of Parkinson disease. Quant Imaging Med Surg 13:6503\u20136516. https:\/\/doi.org\/10.21037\/qims-23-87","journal-title":"Quant Imaging Med Surg"},{"key":"7505_CR43","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s13311-023-01379-z","volume":"20","author":"DG Coughlin","year":"2023","unstructured":"Coughlin DG, Irwin DJ (2023) Fluid and biopsy based biomarkers in Parkinson\u2019s disease. Neurotherapeutics 20:932\u2013954. https:\/\/doi.org\/10.1007\/s13311-023-01379-z","journal-title":"Neurotherapeutics"},{"key":"7505_CR44","doi-asserted-by":"publisher","unstructured":"Constantinescu R, Mondello S (2013) Cerebrospinal fluid biomarker candidates for parkinsonian disorders. Front Neur 3. https:\/\/doi.org\/10.3389\/fneur.2012.00187","DOI":"10.3389\/fneur.2012.00187"},{"key":"7505_CR45","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/mds.27136","volume":"32","author":"L Parnetti","year":"2017","unstructured":"Parnetti L, Paciotti S, Eusebi P et al (2017) Cerebrospinal fluid \u03b2-glucocerebrosidase activity is reduced in Parkinson\u2019s disease patients. Mov Disord 32:1423\u20131431. https:\/\/doi.org\/10.1002\/mds.27136","journal-title":"Mov Disord"},{"key":"7505_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-020-00362-y","volume":"15","author":"H Lowes","year":"2020","unstructured":"Lowes H, Pyle A, Santibanez-Koref M, Hudson G (2020) Circulating cell-free mitochondrial DNA levels in Parkinson\u2019s disease are influenced by treatment. Mol Neurodegener 15:10. https:\/\/doi.org\/10.1186\/s13024-020-00362-y","journal-title":"Mol Neurodegener"},{"key":"7505_CR47","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1038\/s41598-023-32480-0","volume":"13","author":"P Youssef","year":"2023","unstructured":"Youssef P, Hughes L, Kim WS et al (2023) Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson\u2019s disease biomarkers using multiplexed single molecule counting. Sci Rep 13:5217. https:\/\/doi.org\/10.1038\/s41598-023-32480-0","journal-title":"Sci Rep"},{"key":"7505_CR48","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/mds.29497","volume":"38","author":"M Xylaki","year":"2023","unstructured":"Xylaki M, Chopra A, Weber S et al (2023) Extracellular vesicles for the diagnosis of Parkinson\u2019s disease: systematic review and meta-analysis. Mov Disord 38:1585\u20131597. https:\/\/doi.org\/10.1002\/mds.29497","journal-title":"Mov Disord"},{"key":"7505_CR49","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M et al (2018) Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 14:577\u2013589. https:\/\/doi.org\/10.1038\/s41582-018-0058-z","journal-title":"Nat Rev Neurol"},{"key":"7505_CR50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12883-020-1608-8","volume":"20","author":"A Santaella","year":"2020","unstructured":"Santaella A, Kuiperij HB, Van Rumund A et al (2020) Inflammation biomarker discovery in Parkinson\u2019s disease and atypical parkinsonisms. BMC Neurol 20:26. https:\/\/doi.org\/10.1186\/s12883-020-1608-8","journal-title":"BMC Neurol"},{"key":"7505_CR51","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/diagnostics11020371","volume":"11","author":"P Pawlik","year":"2021","unstructured":"Pawlik P, B\u0142ochowiak K (2021) The role of salivary biomarkers in the early diagnosis of Alzheimer\u2019s disease and Parkinson\u2019s disease. Diagnostics 11:371. https:\/\/doi.org\/10.3390\/diagnostics11020371","journal-title":"Diagnostics"},{"key":"7505_CR52","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/mds.29340","volume":"38","author":"A Kuzkina","year":"2023","unstructured":"Kuzkina A, Panzer C, Seger A et al (2023) Dermal real-time quaking-induced conversion is a sensitive marker to confirm isolated rapid eye movement sleep behavior disorder as an early \u03b1-synucleinopathy. Mov Disord 38:1077\u20131082. https:\/\/doi.org\/10.1002\/mds.29340","journal-title":"Mov Disord"},{"key":"7505_CR53","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S1474-4422(16)00080-6","volume":"15","author":"D Vilas","year":"2016","unstructured":"Vilas D, Iranzo A, Tolosa E et al (2016) Assessment of \u03b1-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study. Lancet Neurol 15:708\u2013718. https:\/\/doi.org\/10.1016\/S1474-4422(16)00080-6","journal-title":"Lancet Neurol"},{"key":"7505_CR54","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/nan.12486","volume":"44","author":"C Ruffmann","year":"2018","unstructured":"Ruffmann C, Bengoa-Vergniory N, Poggiolini I et al (2018) Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson\u2019s disease. Neuropathol Appl Neurobiol 44:722\u2013736. https:\/\/doi.org\/10.1111\/nan.12486","journal-title":"Neuropathol Appl Neurobiol"},{"key":"7505_CR55","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s11011-021-00735-2","volume":"37","author":"B Giri","year":"2022","unstructured":"Giri B, Seamon M, Banerjee A et al (2022) Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson\u2019s disease. Metab Brain Dis 37:1687\u20131696. https:\/\/doi.org\/10.1007\/s11011-021-00735-2","journal-title":"Metab Brain Dis"},{"key":"7505_CR56","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1021\/acscentsci.8b00879","volume":"5","author":"DK Trivedi","year":"2019","unstructured":"Trivedi DK, Sinclair E, Xu Y et al (2019) Discovery of volatile biomarkers of Parkinson\u2019s disease from sebum. ACS Cent Sci 5:599\u2013606. https:\/\/doi.org\/10.1021\/acscentsci.8b00879","journal-title":"ACS Cent Sci"},{"key":"7505_CR57","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1021\/jacsau.2c00300","volume":"2","author":"D Sarkar","year":"2022","unstructured":"Sarkar D, Sinclair E, Lim SH et al (2022) Paper spray ionization ion mobility mass spectrometry of sebum classifies biomarker classes for the diagnosis of Parkinson\u2019s disease. JACS Au 2:2013\u20132022. https:\/\/doi.org\/10.1021\/jacsau.2c00300","journal-title":"JACS Au"},{"key":"7505_CR58","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1002\/mds.29515","volume":"38","author":"P Schlie\u00dfer","year":"2023","unstructured":"Schlie\u00dfer P, Struebing FL, Northoff BH et al (2023) Detection of a Parkinson\u2019s disease\u2013specific microRNA signature in nasal and oral swabs. Mov Disord 38:1706\u20131715. https:\/\/doi.org\/10.1002\/mds.29515","journal-title":"Mov Disord"},{"key":"7505_CR59","doi-asserted-by":"publisher","first-page":"631553","DOI":"10.3389\/fnmol.2021.631553","volume":"14","author":"Y Yang","year":"2021","unstructured":"Yang Y, Li Y, Yang H et al (2021) Circulating micrornas and long non-coding rnas as potential diagnostic biomarkers for Parkinson\u2019s disease. Front Mol Neurosci 14:631553. https:\/\/doi.org\/10.3389\/fnmol.2021.631553","journal-title":"Front Mol Neurosci"},{"key":"7505_CR60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13024-021-00425-8","volume":"16","author":"Y Shao","year":"2021","unstructured":"Shao Y, Li T, Liu Z et al (2021) Comprehensive metabolic profiling of Parkinson\u2019s disease by liquid chromatography-mass spectrometry. Mol Neurodegener 16:4. https:\/\/doi.org\/10.1186\/s13024-021-00425-8","journal-title":"Mol Neurodegener"},{"key":"7505_CR61","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/mds.27173","volume":"32","author":"W Han","year":"2017","unstructured":"Han W, Sapkota S, Camicioli R et al (2017) Profiling novel metabolic biomarkers for Parkinson\u2019s disease using in-depth metabolomic analysis. Mov Disord 32:1720\u20131728. https:\/\/doi.org\/10.1002\/mds.27173","journal-title":"Mov Disord"},{"issue":"3","key":"7505_CR62","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/metabo7030042","volume":"7","author":"J Havelund","year":"2017","unstructured":"Havelund J, Heegaard N, F\u00e6rgeman N, Gramsbergen J (2017) Biomarker research in Parkinson\u2019s disease using metabolite profiling. Metabolites 7(3):42. https:\/\/doi.org\/10.3390\/metabo7030042","journal-title":"Metabolites"},{"key":"7505_CR63","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41531-024-00671-9","volume":"10","author":"EG De Lope","year":"2024","unstructured":"De Lope EG, Loo RTJ, Rauschenberger A et al (2024) Comprehensive blood metabolomics profiling of Parkinson\u2019s disease reveals coordinated alterations in xanthine metabolism. NPJ Parkinsons Dis 10:68. https:\/\/doi.org\/10.1038\/s41531-024-00671-9","journal-title":"NPJ Parkinsons Dis"},{"key":"7505_CR64","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger GU, Adler CH, Berg D et al (2024) A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol 23:191\u2013204. https:\/\/doi.org\/10.1016\/S1474-4422(23)00404-0","journal-title":"Lancet Neurol"},{"key":"7505_CR65","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/brain\/awq008","volume":"133","author":"Z Hong","year":"2010","unstructured":"Hong Z, Shi M, Chung KA et al (2010) DJ-1 and \u03b1-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease. Brain 133:713\u2013726. https:\/\/doi.org\/10.1093\/brain\/awq008","journal-title":"Brain"},{"key":"7505_CR66","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3390\/biom12020329","volume":"12","author":"EH Kwon","year":"2022","unstructured":"Kwon EH, Tennagels S, Gold R et al (2022) Update on CSF biomarkers in Parkinson\u2019s disease. Biomolecules 12:329. https:\/\/doi.org\/10.3390\/biom12020329","journal-title":"Biomolecules"},{"key":"7505_CR67","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/mds.26754","volume":"31","author":"NK Majbour","year":"2016","unstructured":"Majbour NK, Vaikath NN, Eusebi P et al (2016) Longitudinal changes in CSF alpha-synuclein species reflect Parkinson\u2019s disease progression. Mov Disord 31:1535\u20131542. https:\/\/doi.org\/10.1002\/mds.26754","journal-title":"Mov Disord"},{"key":"7505_CR68","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-015-0185-3","volume":"3","author":"T Stewart","year":"2015","unstructured":"Stewart T, Sossi V, Aasly JO et al (2015) Phosphorylated \u03b1-synuclein in Parkinson\u2019s disease: correlation depends on disease severity. Acta Neuropathol Commun 3:7. https:\/\/doi.org\/10.1186\/s40478-015-0185-3","journal-title":"Acta Neuropathol Commun"},{"key":"7505_CR69","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41531-021-00232-4","volume":"7","author":"C Quadalti","year":"2021","unstructured":"Quadalti C, Calandra-Buonaura G, Baiardi S et al (2021) Neurofilament light chain and \u03b1-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes. NPJ Parkinsons Dis 7:93. https:\/\/doi.org\/10.1038\/s41531-021-00232-4","journal-title":"NPJ Parkinsons Dis"},{"key":"7505_CR70","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/mds.27897","volume":"35","author":"LP Oosterveld","year":"2020","unstructured":"Oosterveld LP, Verberk IMW, Majbour NK et al (2020) CSF or serum neurofilament light added to \u03b1-synuclein panel discriminates Parkinson\u2019s from controls. Mov Disord 35:288\u2013295. https:\/\/doi.org\/10.1002\/mds.27897","journal-title":"Mov Disord"},{"key":"7505_CR71","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.parkreldis.2013.09.003","volume":"20","author":"MK Herbert","year":"2014","unstructured":"Herbert MK, Eeftens JM, Aerts MB et al (2014) CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls. Parkinsonism Relat Disord 20:112\u2013115. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.09.003","journal-title":"Parkinsonism Relat Disord"},{"key":"7505_CR72","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.expneurol.2017.06.017","volume":"298","author":"GF Crotty","year":"2017","unstructured":"Crotty GF, Ascherio A, Schwarzschild MA (2017) Targeting urate to reduce oxidative stress in Parkinson disease. Exp Neurol 298:210\u2013224. https:\/\/doi.org\/10.1016\/j.expneurol.2017.06.017","journal-title":"Exp Neurol"},{"key":"7505_CR73","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/brainsci10070466","volume":"10","author":"T Katayama","year":"2020","unstructured":"Katayama T, Sawada J, Takahashi K, Yahara O (2020) Cerebrospinal fluid biomarkers in Parkinson\u2019s disease: a critical overview of the literature and meta-analyses. Brain Sci 10:466. https:\/\/doi.org\/10.3390\/brainsci10070466","journal-title":"Brain Sci"},{"key":"7505_CR74","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.3389\/fimmu.2018.02122","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Hu Y, Cao Z et al (2018) Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer\u2019s disease, Parkinson\u2019s disease and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Front Immunol 9:2122. https:\/\/doi.org\/10.3389\/fimmu.2018.02122","journal-title":"Front Immunol"},{"key":"7505_CR75","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1002\/mds.23287","volume":"25","author":"TJ Montine","year":"2010","unstructured":"Montine TJ, Shi M, Quinn JF et al (2010) CSF A\u03b242 and tau in Parkinson\u2019s disease with cognitive impairment. Mov Disord 25:2682\u20132685. https:\/\/doi.org\/10.1002\/mds.23287","journal-title":"Mov Disord"},{"key":"7505_CR76","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1212\/WNL.0000000000003840","volume":"88","author":"L Rochester","year":"2017","unstructured":"Rochester L, Galna B, Lord S et al (2017) Decrease in A\u03b242 predicts dopa-resistant gait progression in early Parkinson disease. Neurology 88:1501\u20131511. https:\/\/doi.org\/10.1212\/WNL.0000000000003840","journal-title":"Neurology"},{"key":"7505_CR77","doi-asserted-by":"publisher","first-page":"37043","DOI":"10.18632\/oncotarget.6158","volume":"6","author":"Y Gui","year":"2015","unstructured":"Gui Y, Liu H, Zhang L et al (2015) Altered microrna profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget 6:37043\u201337053. https:\/\/doi.org\/10.18632\/oncotarget.6158","journal-title":"Oncotarget"},{"key":"7505_CR78","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/ana.24515","volume":"78","author":"A Pyle","year":"2015","unstructured":"Pyle A, Brennan R, Kurzawa-Akanbi M et al (2015) Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early-stage Parkinson\u2019s disease. Ann Neurol 78:1000\u20131004. https:\/\/doi.org\/10.1002\/ana.24515","journal-title":"Ann Neurol"},{"key":"7505_CR79","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/acn3.729","volume":"6","author":"ASL Ng","year":"2019","unstructured":"Ng ASL, Tan YJ, Lu Z et al (2019) Plasma alpha-synuclein detected by single molecule array is increased in PD. Ann Clin Transl Neurol 6:615\u2013619. https:\/\/doi.org\/10.1002\/acn3.729","journal-title":"Ann Clin Transl Neurol"},{"key":"7505_CR80","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fnagi.2020.00112","volume":"12","author":"N-C Chen","year":"2020","unstructured":"Chen N-C, Chen H-L, Li S-H et al (2020) Plasma levels of \u03b1-synuclein, A\u03b2-40 and T-tau as biomarkers to predict cognitive impairment in Parkinson\u2019s disease. Front Aging Neurosci 12:112. https:\/\/doi.org\/10.3389\/fnagi.2020.00112","journal-title":"Front Aging Neurosci"},{"key":"7505_CR81","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1096\/fj.10-179192","volume":"25","author":"PG Foulds","year":"2011","unstructured":"Foulds PG, Mitchell JD, Parker A et al (2011) Phosphorylated \u03b1-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson\u2019s disease. FASEB j 25:4127\u20134137. https:\/\/doi.org\/10.1096\/fj.10-179192","journal-title":"FASEB j"},{"key":"7505_CR82","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/srep02540","volume":"3","author":"PG Foulds","year":"2013","unstructured":"Foulds PG, Diggle P, Mitchell JD et al (2013) A longitudinal study on \u03b1-synuclein in blood plasma as a biomarker for Parkinson\u2019s disease. Sci Rep 3:2540. https:\/\/doi.org\/10.1038\/srep02540","journal-title":"Sci Rep"},{"key":"7505_CR83","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/mds.28206","volume":"35","author":"B Mollenhauer","year":"2020","unstructured":"Mollenhauer B, Dakna M, Kruse N et al (2020) Validation of serum neurofilament light chain as a biomarker of Parkinson\u2019s disease progression. Mov Disord 35:1999\u20132008. https:\/\/doi.org\/10.1002\/mds.28206","journal-title":"Mov Disord"},{"key":"7505_CR84","doi-asserted-by":"publisher","first-page":"30793","DOI":"10.1038\/srep30793","volume":"6","author":"Y Saito","year":"2016","unstructured":"Saito Y, Akazawa-Ogawa Y, Matsumura A et al (2016) Oxidation and interaction of DJ-1 with 20S proteasome in the erythrocytes of early stage Parkinson\u2019s disease patients. Sci Rep 6:30793. https:\/\/doi.org\/10.1038\/srep30793","journal-title":"Sci Rep"},{"key":"7505_CR85","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/mds.27888","volume":"35","author":"M Lawton","year":"2020","unstructured":"Lawton M, Baig F, Toulson G et al (2020) Blood biomarkers with Parkinson\u2019s disease clusters and prognosis: the Oxford discovery cohort. Mov Disord 35:279\u2013287. https:\/\/doi.org\/10.1002\/mds.27888","journal-title":"Mov Disord"},{"key":"7505_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2020.12.020","volume":"84","author":"C Koros","year":"2021","unstructured":"Koros C, Simitsi A-M, Papagiannakis N et al (2021) Serum uric acid level as a putative biomarker in Parkinson\u2019s disease patients carrying GBA1 mutations: 2-year data from the PPMI study. Parkinsonism Relat Disord 84:1\u20134. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.12.020","journal-title":"Parkinsonism Relat Disord"},{"key":"7505_CR87","doi-asserted-by":"publisher","first-page":"1104393","DOI":"10.3389\/fcell.2023.1104393","volume":"11","author":"J Fu","year":"2023","unstructured":"Fu J, Chen S, Liu J et al (2023) Serum inflammatory cytokines levels and the correlation analyses in Parkinson\u2019s disease. Front Cell Dev Biol 11:1104393. https:\/\/doi.org\/10.3389\/fcell.2023.1104393","journal-title":"Front Cell Dev Biol"},{"key":"7505_CR88","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41531-024-00791-2","volume":"10","author":"N Shaheen","year":"2024","unstructured":"Shaheen N, Shaheen A, Osama M et al (2024) Micrornas regulation in Parkinson\u2019s disease, and their potential role as diagnostic and therapeutic targets. NPJ Parkinsons Dis 10:186. https:\/\/doi.org\/10.1038\/s41531-024-00791-2","journal-title":"NPJ Parkinsons Dis"},{"key":"7505_CR89","doi-asserted-by":"publisher","first-page":"216.e7","DOI":"10.1016\/j.neurobiolaging.2015.10.033","volume":"38","author":"A Pyle","year":"2016","unstructured":"Pyle A, Anugrha H, Kurzawa-Akanbi M et al (2016) Reduced mitochondrial DNA copy number is a biomarker of Parkinson\u2019s disease. Neurobiol Aging 38:216.e7-216.e10. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.10.033","journal-title":"Neurobiol Aging"},{"key":"7505_CR90","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.parkreldis.2019.02.014","volume":"63","author":"G Vivacqua","year":"2019","unstructured":"Vivacqua G, Suppa A, Mancinelli R et al (2019) Salivary alpha-synuclein in the diagnosis of Parkinson\u2019s disease and progressive supranuclear palsy. Parkinsonism Relat Disord 63:143\u2013148. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.02.014","journal-title":"Parkinsonism Relat Disord"},{"key":"7505_CR91","doi-asserted-by":"publisher","first-page":"e0151156","DOI":"10.1371\/journal.pone.0151156","volume":"11","author":"G Vivacqua","year":"2016","unstructured":"Vivacqua G, Latorre A, Suppa A et al (2016) Abnormal salivary total and oligomeric alpha-synuclein in Parkinson\u2019s disease. PLoS ONE 11:e0151156. https:\/\/doi.org\/10.1371\/journal.pone.0151156","journal-title":"PLoS ONE"},{"key":"7505_CR92","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s41983-020-0159-7","volume":"56","author":"H Shaheen","year":"2020","unstructured":"Shaheen H, Sobhy S, El Mously S et al (2020) Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson\u2019s disease. Egypt J Neurol Psychiatry Neurosurg 56:22. https:\/\/doi.org\/10.1186\/s41983-020-0159-7","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"7505_CR93","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.parkreldis.2015.07.021","volume":"21","author":"JM Masters","year":"2015","unstructured":"Masters JM, Noyce AJ, Warner TT et al (2015) Elevated salivary protein in Parkinson\u2019s disease and salivary DJ-1 as a potential marker of disease severity. Parkinsonism Relat Disord 21:1251\u20131255. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.07.021","journal-title":"Parkinsonism Relat Disord"},{"key":"7505_CR94","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/mds.27935","volume":"35","author":"M Cressatti","year":"2020","unstructured":"Cressatti M, Juwara L, Galindez JM et al (2020) Salivary microR-153 and microR-223 levels as potential diagnostic biomarkers of idiopathic Parkinson\u2019s disease. Mov Disord 35:468\u2013477. https:\/\/doi.org\/10.1002\/mds.27935","journal-title":"Mov Disord"},{"key":"7505_CR95","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-017-1684-z","volume":"133","author":"K Doppler","year":"2017","unstructured":"Doppler K, Jentschke H-M, Schulmeyer L et al (2017) Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson\u2019s disease. Acta Neuropathol 133:535\u2013545. https:\/\/doi.org\/10.1007\/s00401-017-1684-z","journal-title":"Acta Neuropathol"},{"key":"7505_CR96","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3233\/JPD-201983","volume":"10","author":"D Nam","year":"2020","unstructured":"Nam D, Lee J-Y, Lee M et al (2020) Detection and assessment of \u03b1-synuclein oligomers in the urine of Parkinson\u2019s DISEASE patients. JPD 10:981\u2013991. https:\/\/doi.org\/10.3233\/JPD-201983","journal-title":"JPD"},{"key":"7505_CR97","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/mds.27392","volume":"33","author":"I Ortu\u00f1o-Lizar\u00e1n","year":"2018","unstructured":"Ortu\u00f1o-Lizar\u00e1n I, Beach TG, Serrano GE et al (2018) Phosphorylated \u03b1-synuclein in the retina is a biomarker of Parkinson\u2019s disease pathology severity. Mov Disord 33:1315\u20131324. https:\/\/doi.org\/10.1002\/mds.27392","journal-title":"Mov Disord"},{"key":"7505_CR98","doi-asserted-by":"publisher","first-page":"8507","DOI":"10.1038\/s41598-020-65503-1","volume":"10","author":"F Maass","year":"2020","unstructured":"Maass F, Rikker S, Dambeck V et al (2020) Increased alpha-synuclein tear fluid levels in patients with Parkinson\u2019s disease. Sci Rep 10:8507. https:\/\/doi.org\/10.1038\/s41598-020-65503-1","journal-title":"Sci Rep"},{"key":"7505_CR99","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/mds.28639","volume":"36","author":"A Stuendl","year":"2021","unstructured":"Stuendl A, Kraus T, Chatterjee M et al (2021) \u0391-synuclein in plasma-derived extracellular vesicles is a potential biomarker of Parkinson\u2019s disease. Mov Disord 36:2508\u20132518. https:\/\/doi.org\/10.1002\/mds.28639","journal-title":"Mov Disord"},{"key":"7505_CR100","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fnagi.2018.00438","volume":"10","author":"Z-H Zhao","year":"2019","unstructured":"Zhao Z-H, Chen Z-T, Zhou R-L et al (2019) Increased DJ-1 and \u03b1-synuclein in plasma neural-derived exosomes as potential markers for Parkinson\u2019s disease. Front Aging Neurosci 10:438. https:\/\/doi.org\/10.3389\/fnagi.2018.00438","journal-title":"Front Aging Neurosci"},{"key":"7505_CR101","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40035-021-00249-y","volume":"10","author":"S He","year":"2021","unstructured":"He S, Huang L, Shao C et al (2021) Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson\u2019s disease. Transl Neurodegener 10:25. https:\/\/doi.org\/10.1186\/s40035-021-00249-y","journal-title":"Transl Neurodegener"},{"key":"7505_CR102","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41596-022-00787-3","volume":"18","author":"L Concha-Marambio","year":"2023","unstructured":"Concha-Marambio L, Pritzkow S, Shahnawaz M et al (2023) Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid. Nat Protoc 18:1179\u20131196. https:\/\/doi.org\/10.1038\/s41596-022-00787-3","journal-title":"Nat Protoc"},{"key":"7505_CR103","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1002\/mds.28715","volume":"36","author":"L Concha-Marambio","year":"2021","unstructured":"Concha-Marambio L, Farris CM, Holguin B et al (2021) Seed amplification assay to diagnose early Parkinson\u2019s and predict dopaminergic deficit progression. Mov Disord 36:2444\u20132446. https:\/\/doi.org\/10.1002\/mds.28715","journal-title":"Mov Disord"},{"key":"7505_CR104","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s40478-021-01282-8","volume":"9","author":"MJ Russo","year":"2021","unstructured":"Russo MJ, Orru CD, Concha-Marambio L et al (2021) High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson\u2019s disease. Acta Neuropathol Commun 9:179. https:\/\/doi.org\/10.1186\/s40478-021-01282-8","journal-title":"Acta Neuropathol Commun"},{"key":"7505_CR105","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cll.2020.04.002","volume":"40","author":"NdoC Ferreira","year":"2020","unstructured":"Ferreira NdoC, Caughey B (2020) Proteopathic seed amplification assays for neurodegenerative disorders. Clin Lab Med 40:257\u2013270. https:\/\/doi.org\/10.1016\/j.cll.2020.04.002","journal-title":"Clin Lab Med"},{"key":"7505_CR106","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/mds.27646","volume":"34","author":"UJ Kang","year":"2019","unstructured":"Kang UJ, Boehme AK, Fairfoul G et al (2019) Comparative study of cerebrospinal fluid \u03b1-synuclein seeding aggregation assays for diagnosis of Parkinson\u2019s disease. Mov Disord 34:536\u2013544. https:\/\/doi.org\/10.1002\/mds.27646","journal-title":"Mov Disord"},{"key":"7505_CR107","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/ijms21030880","volume":"21","author":"M Fiorini","year":"2020","unstructured":"Fiorini M, Iselle G, Perra D et al (2020) High diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD. Int J Mol Sci 21:880. https:\/\/doi.org\/10.3390\/ijms21030880","journal-title":"Int J Mol Sci"},{"key":"7505_CR108","doi-asserted-by":"publisher","first-page":"e02451\u201314","DOI":"10.1128\/mBio.02451-14","volume":"6","author":"CD Orr\u00fa","year":"2015","unstructured":"Orr\u00fa CD, Groveman BR, Hughson AG et al (2015) Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. MBio 6:e02451\u201314. https:\/\/doi.org\/10.1128\/mBio.02451-14","journal-title":"MBio"},{"key":"7505_CR109","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng C, Gathagan RJ, Covell DJ et al (2018) Cellular milieu imparts distinct pathological \u03b1-synuclein strains in \u03b1-synucleinopathies. Nature 557:558\u2013563. https:\/\/doi.org\/10.1038\/s41586-018-0104-4","journal-title":"Nature"},{"key":"7505_CR110","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40478-018-0532-2","volume":"6","author":"A Tarutani","year":"2018","unstructured":"Tarutani A, Arai T, Murayama S et al (2018) Potent prion-like behaviors of pathogenic \u03b1-synuclein and evaluation of inactivation methods. Acta Neuropathol Commun 6:29. https:\/\/doi.org\/10.1186\/s40478-018-0532-2","journal-title":"Acta Neuropathol Commun"},{"key":"7505_CR111","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf A, Concha-Marambio L, Lafontant D-E et al (2023) Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol 22:407\u2013417. https:\/\/doi.org\/10.1016\/S1474-4422(23)00109-6","journal-title":"Lancet Neurol"},{"key":"7505_CR112","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S et al (2020) Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578:273\u2013277. https:\/\/doi.org\/10.1038\/s41586-020-1984-7","journal-title":"Nature"},{"key":"7505_CR113","doi-asserted-by":"publisher","unstructured":"Majbour N, Aasly J, Abdi I, et al (2022) Disease-associated \u03b1-synuclein aggregates as biomarkers of Parkinson disease clinical stage. Neurology 99:. https:\/\/doi.org\/10.1212\/WNL.0000000000201199","DOI":"10.1212\/WNL.0000000000201199"},{"key":"7505_CR114","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","volume":"3","author":"G Fairfoul","year":"2016","unstructured":"Fairfoul G, McGuire LI, Pal S et al (2016) Alpha-synuclein RT-Qu IC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol 3:812\u2013818. https:\/\/doi.org\/10.1002\/acn3.338","journal-title":"Ann Clin Transl Neurol"},{"key":"7505_CR115","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/acn3.50897","volume":"6","author":"M Bongianni","year":"2019","unstructured":"Bongianni M, Ladogana A, Capaldi S et al (2019) \u03b1-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies. Ann Clin Transl Neurol 6:2120\u20132126. https:\/\/doi.org\/10.1002\/acn3.50897","journal-title":"Ann Clin Transl Neurol"},{"key":"7505_CR116","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi M, Candelise N, Baiardi S et al (2020) Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol 140:49\u201362. https:\/\/doi.org\/10.1007\/s00401-020-02160-8","journal-title":"Acta Neuropathol"},{"key":"7505_CR117","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s40478-021-01276-6","volume":"9","author":"K Brockmann","year":"2021","unstructured":"Brockmann K, Quadalti C, Lerche S et al (2021) Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson\u2019s disease and dementia with Lewy bodies. Acta Neuropathol Commun 9:175. https:\/\/doi.org\/10.1186\/s40478-021-01276-6","journal-title":"Acta Neuropathol Commun"},{"key":"7505_CR118","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/brain\/awab431","volume":"145","author":"I Poggiolini","year":"2022","unstructured":"Poggiolini I, Gupta V, Lawton M et al (2022) Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies. Brain 145:584\u2013595. https:\/\/doi.org\/10.1093\/brain\/awab431","journal-title":"Brain"},{"key":"7505_CR119","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","volume":"74","author":"M Shahnawaz","year":"2017","unstructured":"Shahnawaz M, Tokuda T, Waragai M et al (2017) Development of a biochemical diagnosis of Parkinson disease by detection of \u03b1-synuclein misfolded aggregates in cerebrospinal fluid. JAMA Neurol 74:163. https:\/\/doi.org\/10.1001\/jamaneurol.2016.4547","journal-title":"JAMA Neurol"},{"key":"7505_CR120","doi-asserted-by":"publisher","first-page":"e2312031121","DOI":"10.1073\/pnas.2312031121","volume":"121","author":"T Gilboa","year":"2024","unstructured":"Gilboa T, Swank Z, Thakur R et al (2024) Toward the quantification of \u03b1-synuclein aggregates with digital seed amplification assays. Proc Natl Acad Sci U S A 121:e2312031121. https:\/\/doi.org\/10.1073\/pnas.2312031121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7505_CR121","doi-asserted-by":"publisher","first-page":"105807","DOI":"10.1016\/j.parkreldis.2023.105807","volume":"117","author":"B Fernandes Gomes","year":"2023","unstructured":"Fernandes Gomes B, Farris CM, Ma Y et al (2023) \u03b1-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders. Parkinsonism Relat Disord 117:105807. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105807","journal-title":"Parkinsonism Relat Disord"},{"key":"7505_CR122","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/mds.27907","volume":"35","author":"S Manne","year":"2020","unstructured":"Manne S, Kondru N, Jin H et al (2020) \u03b1-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson\u2019s disease patients. Mov Disord 35:268\u2013278. https:\/\/doi.org\/10.1002\/mds.27907","journal-title":"Mov Disord"},{"key":"7505_CR123","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40035-019-0164-x","volume":"8","author":"CMG De Luca","year":"2019","unstructured":"De Luca CMG, Elia AE, Portaleone SM et al (2019) Efficient RT-QuIC seeding activity for \u03b1-synuclein in olfactory mucosa samples of patients with Parkinson\u2019s disease and multiple system atrophy. Transl Neurodegener 8:24. https:\/\/doi.org\/10.1186\/s40035-019-0164-x","journal-title":"Transl Neurodegener"},{"key":"7505_CR124","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1093\/brain\/awac115","volume":"145","author":"A Kluge","year":"2022","unstructured":"Kluge A, Bunk J, Schaeffer E et al (2022) Detection of neuron-derived pathological \u03b1-synuclein in blood. Brain 145:3058\u20133071. https:\/\/doi.org\/10.1093\/brain\/awac115","journal-title":"Brain"},{"key":"7505_CR125","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41531-021-00242-2","volume":"7","author":"A Kuzkina","year":"2021","unstructured":"Kuzkina A, Bargar C, Schmitt D et al (2021) Diagnostic value of skin RT-QuIC in Parkinson\u2019s disease: a two-laboratory study. NPJ Parkinsons Dis 7:99. https:\/\/doi.org\/10.1038\/s41531-021-00242-2","journal-title":"NPJ Parkinsons Dis"},{"key":"7505_CR126","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamaneurol.2020.3311","volume":"78","author":"Z Wang","year":"2021","unstructured":"Wang Z, Becker K, Donadio V et al (2021) Skin \u03b1-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease. JAMA Neurol 78:30. https:\/\/doi.org\/10.1001\/jamaneurol.2020.3311","journal-title":"JAMA Neurol"},{"key":"7505_CR127","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1002\/mds.28242","volume":"35","author":"S Manne","year":"2020","unstructured":"Manne S, Kondru N, Jin H et al (2020) Blinded RT-QuIC analysis of \u03b1-synuclein biomarker in skin tissue from Parkinson\u2019s disease patients. Mov Disord 35:2230\u20132239. https:\/\/doi.org\/10.1002\/mds.28242","journal-title":"Mov Disord"},{"key":"7505_CR128","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","volume":"29","author":"A Okuzumi","year":"2023","unstructured":"Okuzumi A, Hatano T, Matsumoto G et al (2023) Propagative \u03b1-synuclein seeds as serum biomarkers for synucleinopathies. Nat Med 29:1448\u20131455. https:\/\/doi.org\/10.1038\/s41591-023-02358-9","journal-title":"Nat Med"},{"key":"7505_CR129","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40035-024-00426-9","volume":"13","author":"H Mao","year":"2024","unstructured":"Mao H, Kuang Y, Feng D et al (2024) Ultrasensitive detection of aggregated \u03b1-synuclein using quiescent seed amplification assay for the diagnosis of Parkinson\u2019s disease. Transl Neurodegener 13:35. https:\/\/doi.org\/10.1186\/s40035-024-00426-9","journal-title":"Transl Neurodegener"},{"key":"7505_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100629","author":"CE Teunissen","year":"2023","unstructured":"Teunissen CE, Kimble L, Bayoumy S et al (2023) Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias. Mol Cell Proteomics. https:\/\/doi.org\/10.1016\/j.mcpro.2023.100629","journal-title":"Mol Cell Proteomics"},{"key":"7505_CR131","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/10408363.2019.1711359","volume":"57","author":"DM O\u2019Hara","year":"2020","unstructured":"O\u2019Hara DM, Kalia SK, Kalia LV (2020) Methods for detecting toxic \u03b1-synuclein species as a biomarker for Parkinson\u2019s disease. Crit Rev Clin Lab Sci 57:291\u2013307. https:\/\/doi.org\/10.1080\/10408363.2019.1711359","journal-title":"Crit Rev Clin Lab Sci"},{"key":"7505_CR132","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41531-021-00262-y","volume":"7","author":"E Vacchi","year":"2021","unstructured":"Vacchi E, Senese C, Chiaro G et al (2021) Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson\u2019s disease. NPJ Parkinsons Dis 7:119. https:\/\/doi.org\/10.1038\/s41531-021-00262-y","journal-title":"NPJ Parkinsons Dis"},{"key":"7505_CR133","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3233\/JPD-213085","volume":"13","author":"R Arlinghaus","year":"2023","unstructured":"Arlinghaus R, Iba M, Masliah E et al (2023) Specific detection of physiological S129 phosphorylated \u03b1-synuclein in tissue using proximity ligation assay. JPD 13:255\u2013270. https:\/\/doi.org\/10.3233\/JPD-213085","journal-title":"JPD"},{"key":"7505_CR134","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/brain\/awaa008","volume":"143","author":"S Mazzetti","year":"2020","unstructured":"Mazzetti S, Basellini MJ, Ferri V et al (2020) \u03b1-synuclein oligomers in skin biopsy of idiopathic and monozygotic twin patients with Parkinson\u2019s disease. Brain 143:920\u2013931. https:\/\/doi.org\/10.1093\/brain\/awaa008","journal-title":"Brain"},{"key":"7505_CR135","doi-asserted-by":"publisher","first-page":"e13284","DOI":"10.1111\/bpa.13284","volume":"34","author":"S Mazzetti","year":"2024","unstructured":"Mazzetti S, Contaldi E, Basellini MJ et al (2024) Comparing GBA1 -Parkinson\u2019s disease and idiopathic Parkinson\u2019s disease: \u03b1-synuclein oligomers and synaptic density as biomarkers in the skin biopsy. Brain Pathol 34:e13284. https:\/\/doi.org\/10.1111\/bpa.13284","journal-title":"Brain Pathol"},{"key":"7505_CR136","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1021\/acschemneuro.3c00617","volume":"15","author":"H Yu","year":"2024","unstructured":"Yu H, Feng R, Chen F et al (2024) Rapid FRET assay for the early detection of alpha-synuclein aggregation in Parkinson\u2019s disease. ACS Chem Neurosci 15:1378\u20131387. https:\/\/doi.org\/10.1021\/acschemneuro.3c00617","journal-title":"ACS Chem Neurosci"},{"key":"7505_CR137","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41531-021-00195-6","volume":"7","author":"AR Braun","year":"2021","unstructured":"Braun AR, Liao EE, Horvath M et al (2021) Potent inhibitors of toxic alpha-synuclein identified via cellular time-resolved FRET biosensors. NPJ Parkinsons Dis 7:52. https:\/\/doi.org\/10.1038\/s41531-021-00195-6","journal-title":"NPJ Parkinsons Dis"},{"key":"7505_CR138","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/jnc.15528","volume":"159","author":"M Galkin","year":"2021","unstructured":"Galkin M, Priss A, Topcheva O et al (2021) FRET-based assay for intracellular evaluation of \u03b1-synuclein aggregation inhibitors. J Neurochem 159:901\u2013912. https:\/\/doi.org\/10.1111\/jnc.15528","journal-title":"J Neurochem"},{"key":"7505_CR139","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G et al (2014) Homogenous 96-Plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE 9:e95192. https:\/\/doi.org\/10.1371\/journal.pone.0095192","journal-title":"PLoS ONE"},{"key":"7505_CR140","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/ejn.16226","volume":"59","author":"BI Arioz","year":"2024","unstructured":"Arioz BI, Cotuk A, Yaka EC, Genc S (2024) Proximity extension assay-based proteomics studies in neurodegenerative disorders and multiple sclerosis. Eur J of Neuroscience 59:1348\u20131358. https:\/\/doi.org\/10.1111\/ejn.16226","journal-title":"Eur J of Neuroscience"},{"key":"7505_CR141","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-023-00374-w","volume":"12","author":"W Paslawski","year":"2023","unstructured":"Paslawski W, Khosousi S, Hertz E et al (2023) Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson\u2019s disease. Transl Neurodegener 12:42. https:\/\/doi.org\/10.1186\/s40035-023-00374-w","journal-title":"Transl Neurodegener"},{"key":"7505_CR142","doi-asserted-by":"publisher","first-page":"e200132","DOI":"10.1212\/NXI.0000000000200132","volume":"10","author":"CC Pedersen","year":"2023","unstructured":"Pedersen CC, Ushakova A, Skogseth RE et al (2023) Inflammatory biomarkers in newly diagnosed patients with Parkinson disease and related neurodegenerative disorders. Neurol Neuroimmunol Neuroinflamm 10:e200132. https:\/\/doi.org\/10.1212\/NXI.0000000000200132","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"7505_CR143","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/brain\/awv099","volume":"138","author":"U Dettmer","year":"2015","unstructured":"Dettmer U, Bartels T (2015) Explaining early synucleinopathies: figure 1. Brain 138:1449\u20131451. https:\/\/doi.org\/10.1093\/brain\/awv099","journal-title":"Brain"},{"key":"7505_CR144","doi-asserted-by":"publisher","first-page":"100168","DOI":"10.1016\/j.mcpro.2021.100168","volume":"20","author":"L Wik","year":"2021","unstructured":"Wik L, Nordberg N, Broberg J et al (2021) Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Mol Cell Proteomics 20:100168. https:\/\/doi.org\/10.1016\/j.mcpro.2021.100168","journal-title":"Mol Cell Proteomics"},{"key":"7505_CR145","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/s41374-022-00830-7","volume":"102","author":"M Cui","year":"2022","unstructured":"Cui M, Cheng C, Zhang L (2022) High-throughput proteomics: a methodological mini-review. Lab Invest 102:1170\u20131181. https:\/\/doi.org\/10.1038\/s41374-022-00830-7","journal-title":"Lab Invest"},{"key":"7505_CR146","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40035-020-00192-4","volume":"9","author":"NK Majbour","year":"2020","unstructured":"Majbour NK, Aasly JO, Hustad E et al (2020) CSF total and oligomeric \u03b1-synuclein along with TNF-\u03b1 as risk biomarkers for Parkinson\u2019s disease: a study in LRRK2 mutation carriers. Transl Neurodegener 9:15. https:\/\/doi.org\/10.1186\/s40035-020-00192-4","journal-title":"Transl Neurodegener"},{"key":"7505_CR147","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41531-022-00362-3","volume":"8","author":"D Urso","year":"2022","unstructured":"Urso D, Van Wamelen DJ, Batzu L et al (2022) Clinical trajectories and biomarkers for weight variability in early Parkinson\u2019s disease. NPJ Parkinsons Dis 8:95. https:\/\/doi.org\/10.1038\/s41531-022-00362-3","journal-title":"NPJ Parkinsons Dis"},{"key":"7505_CR148","doi-asserted-by":"publisher","first-page":"e2223821","DOI":"10.1001\/jamanetworkopen.2022.23821","volume":"5","author":"L Wang","year":"2022","unstructured":"Wang L, Zhang W, Liu F et al (2022) Association of cerebrospinal fluid neurofilament heavy protein levels with clinical progression in patients with Parkinson disease. JAMA Netw Open 5:e2223821. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.23821","journal-title":"JAMA Netw Open"},{"issue":"1","key":"7505_CR149","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41531-023-00542-9","volume":"9","author":"M D\u00fcchs","year":"2023","unstructured":"D\u00fcchs M, Blazevic D, Rechtsteiner P et al (2023) AAV-mediated expression of a new conformational anti-aggregated \u03b1-synuclein antibody prolongs survival in a genetic model of \u03b1-synucleinopathies. NPJ Parkinsons Dis 9(1):91. https:\/\/doi.org\/10.1038\/s41531-023-00542-9","journal-title":"NPJ Parkinsons Dis"},{"key":"7505_CR150","doi-asserted-by":"crossref","unstructured":"Lucena DD, Escaramis G, Villar-Piqu\u00e9 A, et al (2020) A new tetra-plex fluorimetric assay for the quantification of cerebrospinal fluid \u03b2-amyloid42, total-tau, phospho-tau and \u03b1-synuclein in the differential diagnosis of neurodegenerative dementia.","DOI":"10.21203\/rs.2.22179\/v1"},{"key":"7505_CR151","doi-asserted-by":"publisher","unstructured":"Hong Z, Tian C, Stewart T, et al (2021) Development of a sensitive diagnostic assay for Parkinson disease quantifying \u03b1-synuclein\u2013containing extracellular vesicles. Neurology 96. https:\/\/doi.org\/10.1212\/WNL.0000000000011853","DOI":"10.1212\/WNL.0000000000011853"},{"key":"7505_CR152","doi-asserted-by":"publisher","unstructured":"Wang Y, Shi M, Chung KA, et al (2012) Phosphorylated \u03b1-synuclein in Parkinson\u2019s disease. Sci Transl Med 4. https:\/\/doi.org\/10.1126\/scitranslmed.3002566","DOI":"10.1126\/scitranslmed.3002566"},{"key":"7505_CR153","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1373\/clinchem.2005.051532","volume":"51","author":"RM Lequin","year":"2005","unstructured":"Lequin RM (2005) Enzyme immunoassay (EIA)\/enzyme-linked immunosorbent assay (ELISA). Clin Chem 51:2415\u20132418. https:\/\/doi.org\/10.1373\/clinchem.2005.051532","journal-title":"Clin Chem"},{"key":"7505_CR154","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jpba.2012.12.002","volume":"76","author":"L Delbroek","year":"2013","unstructured":"Delbroek L, Van Kolen K, Steegmans L et al (2013) Development of an enzyme-linked immunosorbent assay for detection of cellular and in vivo LRRK2 S935 phosphorylation. J Pharm Biomed Anal 76:49\u201358. https:\/\/doi.org\/10.1016\/j.jpba.2012.12.002","journal-title":"J Pharm Biomed Anal"},{"key":"7505_CR155","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1021\/jm5014055","volume":"58","author":"JL Henderson","year":"2015","unstructured":"Henderson JL, Kormos BL, Hayward MM et al (2015) Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7 H -pyrrolo[2,3- d ]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor. J Med Chem 58:419\u2013432. https:\/\/doi.org\/10.1021\/jm5014055","journal-title":"J Med Chem"},{"key":"7505_CR156","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/19768354.2021.1883735","volume":"25","author":"D Nam","year":"2021","unstructured":"Nam D, Kim A, Han SJ et al (2021) Analysis of \u03b1-synuclein levels related to LRRK2 kinase activity: from substantia nigra to urine of patients with Parkinson\u2019s disease. Anim Cells Syst 25:28\u201336. https:\/\/doi.org\/10.1080\/19768354.2021.1883735","journal-title":"Anim Cells Syst"},{"key":"7505_CR157","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40035-019-0155-y","volume":"8","author":"C Tian","year":"2019","unstructured":"Tian C, Liu G, Gao L et al (2019) Erythrocytic \u03b1-synuclein as a potential biomarker for Parkinson\u2019s disease. Transl Neurodegener 8:15. https:\/\/doi.org\/10.1186\/s40035-019-0155-y","journal-title":"Transl Neurodegener"},{"key":"7505_CR158","doi-asserted-by":"publisher","first-page":"867528","DOI":"10.3389\/fnagi.2022.867528","volume":"14","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Yu Z, Zhao J et al (2022) Oral mucosa derived \u03b1\u2212synuclein as a potential diagnostic biomarker for Parkinson\u2019s disease. Front Aging Neurosci 14:867528. https:\/\/doi.org\/10.3389\/fnagi.2022.867528","journal-title":"Front Aging Neurosci"},{"key":"7505_CR159","doi-asserted-by":"publisher","DOI":"10.1080\/17576180.2024.2407718","author":"AM Silva","year":"2024","unstructured":"Silva AM, Hickford ES, Cutler P (2024) An immunoassay for the quantification of phosphorylated \u03b1-synuclein at serine 129 in human cerebrospinal fluid. Bioanalysis. https:\/\/doi.org\/10.1080\/17576180.2024.2407718","journal-title":"Bioanalysis"},{"key":"7505_CR160","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s11357-022-00576-6","volume":"44","author":"C-W Lin","year":"2022","unstructured":"Lin C-W, Lai T-T, Chen S-J, Lin C-H (2022) Elevated \u03b1-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson\u2019s disease. GeroScience 44:1551\u20131562. https:\/\/doi.org\/10.1007\/s11357-022-00576-6","journal-title":"GeroScience"},{"key":"7505_CR161","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1093\/brain\/awad169","volume":"146","author":"S Yan","year":"2023","unstructured":"Yan S, Jiang C, Davis JJ, Tofaris GK (2023) Methodological considerations in neuronal extracellular vesicle isolation for \u03b1-synuclein biomarkers. Brain 146:e95\u2013e97. https:\/\/doi.org\/10.1093\/brain\/awad169","journal-title":"Brain"},{"key":"7505_CR162","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jamaneurol.2023.4398","volume":"81","author":"S Yan","year":"2024","unstructured":"Yan S, Jiang C, Janzen A et al (2024) Neuronally derived extracellular vesicle \u03b1-synuclein as a serum biomarker for individuals at risk of developing Parkinson disease. JAMA Neurol 81:59. https:\/\/doi.org\/10.1001\/jamaneurol.2023.4398","journal-title":"JAMA Neurol"},{"key":"7505_CR163","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/jnnp-2019-322588","volume":"91","author":"C Jiang","year":"2020","unstructured":"Jiang C, Hopfner F, Katsikoudi A et al (2020) Serum neuronal exosomes predict and differentiate Parkinson\u2019s disease from atypical parkinsonism. J Neurol Neurosurg Psychiatry 91:720\u2013729. https:\/\/doi.org\/10.1136\/jnnp-2019-322588","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7505_CR164","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1002\/mds.28591","volume":"36","author":"C Jiang","year":"2021","unstructured":"Jiang C, Hopfner F, Berg D et al (2021) Validation of \u03b1-synuclein in L1CAM -immunocaptured exosomes as a biomarker for the stratification of parkinsonian syndromes. Mov Disord 36:2663\u20132669. https:\/\/doi.org\/10.1002\/mds.28591","journal-title":"Mov Disord"},{"key":"7505_CR165","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1021\/acschemneuro.2c00676","volume":"14","author":"S Dutta","year":"2023","unstructured":"Dutta S, Hornung S, Taha HB et al (2023) Development of a novel electrochemiluminescence ELISA for quantification of \u03b1-synuclein phosphorylated at Ser129 in biological samples. ACS Chem Neurosci 14:1238\u20131248. https:\/\/doi.org\/10.1021\/acschemneuro.2c00676","journal-title":"ACS Chem Neurosci"},{"key":"7505_CR166","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/aji.12512","volume":"75","author":"P Aldo","year":"2016","unstructured":"Aldo P, Marusov G, Svancara D et al (2016) Simple Plex\u2122\u202f: a novel multi-analyte, automated microfluidic immunoassay platform for the detection of human and mouse cytokines and chemokines. Am J Reprod Immunol 75:678\u2013693. https:\/\/doi.org\/10.1111\/aji.12512","journal-title":"Am J Reprod Immunol"},{"key":"7505_CR167","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1136\/jnnp-2021-327129","volume":"93","author":"S Halbgebauer","year":"2022","unstructured":"Halbgebauer S, Steinacker P, Verde F et al (2022) Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS. J Neurol Neurosurg Psychiatry 93:68\u201374. https:\/\/doi.org\/10.1136\/jnnp-2021-327129","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7505_CR168","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/acn3.51355","volume":"8","author":"A Gauthier","year":"2021","unstructured":"Gauthier A, Viel S, Perret M et al (2021) Comparison of Simoa\u2122 and Ella\u2122 to assess serum neurofilament-light chain in multiple sclerosis. Ann Clin Transl Neurol 8:1141\u20131150. https:\/\/doi.org\/10.1002\/acn3.51355","journal-title":"Ann Clin Transl Neurol"},{"key":"7505_CR169","doi-asserted-by":"publisher","first-page":"12361","DOI":"10.3390\/ijms232012361","volume":"23","author":"M N\u00f6tzel","year":"2022","unstructured":"N\u00f6tzel M, Werder LI, Ziemssen T, Akg\u00fcn K (2022) Ella versus simoa serum neurofilament assessment to monitor treatment response in highly active multiple sclerosis patients. IJMS 23:12361. https:\/\/doi.org\/10.3390\/ijms232012361","journal-title":"IJMS"},{"key":"7505_CR170","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jim.2016.08.003","volume":"437","author":"D Yeung","year":"2016","unstructured":"Yeung D, Ciotti S, Purushothama S et al (2016) Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg\/mL levels of cytokines in human serum. J Immunol Methods 437:53\u201363. https:\/\/doi.org\/10.1016\/j.jim.2016.08.003","journal-title":"J Immunol Methods"},{"key":"7505_CR171","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2147\/DNND.S471174","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Bi K, Zhou L et al (2024) Advances in blood biomarkers for Alzheimer\u2019s disease: ultra-sensitive detection technologies and impact on clinical diagnosis. DNND 14:85\u2013102. https:\/\/doi.org\/10.2147\/DNND.S471174","journal-title":"DNND"},{"key":"7505_CR172","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","volume":"26","author":"EH Thijssen","year":"2020","unstructured":"Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) investigators, Thijssen EH, La Joie R et al (2020) Diagnostic value of plasma phosphorylated tau181 in Alzheimer\u2019s disease and frontotemporal lobar degeneration. Nat Med 26:387\u2013397. https:\/\/doi.org\/10.1038\/s41591-020-0762-2","journal-title":"Nat Med"},{"key":"7505_CR173","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen CE, Verberk IMW, Thijssen EH et al (2022) Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol 21:66\u201377. https:\/\/doi.org\/10.1016\/S1474-4422(21)00361-6","journal-title":"Lancet Neurol"},{"key":"7505_CR174","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari TK, Pascoal TA, Ashton NJ et al (2020) Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol 19:422\u2013433. https:\/\/doi.org\/10.1016\/S1474-4422(20)30071-5","journal-title":"Lancet Neurol"},{"key":"7505_CR175","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.expneurol.2006.12.006","volume":"204","author":"Q-X Li","year":"2007","unstructured":"Li Q-X, Mok SS, Laughton KM et al (2007) Plasma \u03b1-synuclein is decreased in subjects with Parkinson\u2019s disease. Exp Neurol 204:583\u2013588. https:\/\/doi.org\/10.1016\/j.expneurol.2006.12.006","journal-title":"Exp Neurol"},{"key":"7505_CR176","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/mds.22928","volume":"25","author":"R Duran","year":"2010","unstructured":"Duran R, Barrero FJ, Morales B et al (2010) Plasma \u03b1-synuclein in patients with Parkinson\u2019s disease with and without treatment. Mov Disord 25:489\u2013493. https:\/\/doi.org\/10.1002\/mds.22928","journal-title":"Mov Disord"},{"key":"7505_CR177","doi-asserted-by":"publisher","first-page":"e52312","DOI":"10.1371\/journal.pone.0052312","volume":"7","author":"A Gorostidi","year":"2012","unstructured":"Gorostidi A, Bergareche A, Ruiz-Mart\u00ednez J et al (2012) \u03b1-Synuclein levels in blood plasma from LRRK2 mutation carriers. PLoS ONE 7:e52312. https:\/\/doi.org\/10.1371\/journal.pone.0052312","journal-title":"PLoS ONE"},{"key":"7505_CR178","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3233\/JPD-212694","volume":"11","author":"P Youssef","year":"2021","unstructured":"Youssef P, Kim WS, Halliday GM et al (2021) Comparison of different platform immunoassays for the measurement of plasma alpha-synuclein in Parkinson\u2019s disease patients. JPD 11:1761\u20131772. https:\/\/doi.org\/10.3233\/JPD-212694","journal-title":"JPD"},{"key":"7505_CR179","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3233\/JPD-191699","volume":"9","author":"HF Green","year":"2019","unstructured":"Green HF, Khosousi S, Svenningsson P (2019) Plasma IL-6 and IL-17A correlate with severity of motor and non-motor symptoms in Parkinson\u2019s disease. JPD 9:705\u2013709. https:\/\/doi.org\/10.3233\/JPD-191699","journal-title":"JPD"},{"key":"7505_CR180","doi-asserted-by":"publisher","first-page":"100027","DOI":"10.1016\/j.cytox.2020.100027","volume":"2","author":"HC Lasseter","year":"2020","unstructured":"Lasseter HC, Provost AC, Chaby LE et al (2020) Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: platform performance in post-traumatic stress disorder and Parkinson\u2019s disease. Cytokine: X 2:100027. https:\/\/doi.org\/10.1016\/j.cytox.2020.100027","journal-title":"Cytokine: X"},{"key":"7505_CR181","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/mds.28399","volume":"36","author":"A Al-Qassabi","year":"2021","unstructured":"Al-Qassabi A, Tsao T, Racolta A et al (2021) Immunohistochemical detection of synuclein pathology in skin in idiopathic rapid eye movement sleep behavior disorder and parkinsonism. Mov Disord 36:895\u2013904. https:\/\/doi.org\/10.1002\/mds.28399","journal-title":"Mov Disord"},{"key":"7505_CR182","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1212\/WNL.0000000000003989","volume":"88","author":"E Antelmi","year":"2017","unstructured":"Antelmi E, Donadio V, Incensi A et al (2017) Skin nerve phosphorylated \u03b1-synuclein deposits in idiopathic REM sleep behavior disorder. Neurology 88:2128\u20132131. https:\/\/doi.org\/10.1212\/WNL.0000000000003989","journal-title":"Neurology"},{"key":"7505_CR183","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/jnen\/nly074","volume":"77","author":"V Donadio","year":"2018","unstructured":"Donadio V, Incensi A, Del Sorbo F et al (2018) Skin nerve phosphorylated \u03b1-synuclein deposits in Parkinson disease with orthostatic hypotension. J Neuropathol Exp Neurol 77:942\u2013949. https:\/\/doi.org\/10.1093\/jnen\/nly074","journal-title":"J Neuropathol Exp Neurol"},{"key":"7505_CR184","doi-asserted-by":"publisher","first-page":"14246","DOI":"10.1038\/s41598-018-32588-8","volume":"8","author":"V Donadio","year":"2018","unstructured":"Donadio V, Incensi A, El-Agnaf O et al (2018) Skin \u03b1-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study. Sci Rep 8:14246. https:\/\/doi.org\/10.1038\/s41598-018-32588-8","journal-title":"Sci Rep"},{"key":"7505_CR185","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neulet.2019.03.054","volume":"704","author":"L-Y Ma","year":"2019","unstructured":"Ma L-Y, Gao L, Li X et al (2019) Nitrated alpha-synuclein in minor salivary gland biopsies in Parkinson\u2019s disease. Neurosci Lett 704:45\u201349. https:\/\/doi.org\/10.1016\/j.neulet.2019.03.054","journal-title":"Neurosci Lett"},{"key":"7505_CR186","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1021\/cn200028j","volume":"2","author":"C-C Yang","year":"2011","unstructured":"Yang C-C, Yang S-Y, Chieh J-J et al (2011) Biofunctionalized magnetic nanoparticles for specifically detecting biomarkers of Alzheimer\u2019s disease in vitro. ACS Chem Neurosci 2:500\u2013505. https:\/\/doi.org\/10.1021\/cn200028j","journal-title":"ACS Chem Neurosci"},{"key":"7505_CR187","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1021\/acsmeasuresciau.3c00029","volume":"3","author":"K-H Lee","year":"2023","unstructured":"Lee K-H, Hsu M-H, Chen H-H, Yang S-Y (2023) Analyzer-to-analyzer variations in assaying ultralow concentrated biomarkers associated with neurodegenerative diseases using immunomagnetic reduction. ACS Meas Sci Au 3:488\u2013495. https:\/\/doi.org\/10.1021\/acsmeasuresciau.3c00029","journal-title":"ACS Meas Sci Au"},{"key":"7505_CR188","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1021\/acsmeasuresciau.2c00030","volume":"2","author":"H-H Chen","year":"2022","unstructured":"Chen H-H, Hsu M-H, Lee K-H, Yang S-Y (2022) Development of a 36-channel instrument for assaying biomarkers of ultralow concentrations utilizing immunomagnetic reduction. ACS Meas Sci Au 2:485\u2013492. https:\/\/doi.org\/10.1021\/acsmeasuresciau.2c00030","journal-title":"ACS Meas Sci Au"},{"key":"7505_CR189","doi-asserted-by":"publisher","first-page":"014703","DOI":"10.1063\/1.2827359","volume":"103","author":"JJ Chieh","year":"2008","unstructured":"Chieh JJ, Yang SY, Jian ZF et al (2008) Hyper-high-sensitivity wash-free magnetoreduction assay on biomolecules using high-Tc superconducting quantum interference devices. J Appl Phys 103:014703. https:\/\/doi.org\/10.1063\/1.2827359","journal-title":"J Appl Phys"},{"key":"7505_CR190","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1109\/TASC.2010.2087304","volume":"21","author":"MJ Chiu","year":"2011","unstructured":"Chiu MJ, Horng HE, Chieh JJ et al (2011) Multi-channel SQUID-based ultra-high-sensitivity in-vitro detections for bio-markers of Alzheimer\u2019s disease via immunomagnetic reduction. IEEE Trans Appl Supercond 21:477\u2013480. https:\/\/doi.org\/10.1109\/TASC.2010.2087304","journal-title":"IEEE Trans Appl Supercond"},{"issue":"4","key":"7505_CR191","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/s18041043","volume":"18","author":"J-J Chieh","year":"2018","unstructured":"Chieh J-J, Wei W-C, Liao S-H et al (2018) Eight-channel AC magnetosusceptometer of magnetic nanoparticles for high-throughput and ultra-high-sensitivity immunoassay. Sensors 18(4):1043. https:\/\/doi.org\/10.3390\/s18041043","journal-title":"Sensors"},{"key":"7505_CR192","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3233\/ADR-240110","volume":"8","author":"GR Malaty","year":"2024","unstructured":"Malaty GR, Decourt B, Shill HA, Sabbagh MN (2024) Biomarker assessment in Parkinson\u2019s disease dementia and dementia with Lewy bodies by the immunomagnetic reduction assay and clinical measures. ADR 8:1361\u20131371. https:\/\/doi.org\/10.3233\/ADR-240110","journal-title":"ADR"},{"key":"7505_CR193","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/cells11081279","volume":"11","author":"R Azevedo","year":"2022","unstructured":"Azevedo R, Jacquemin C, Villain N et al (2022) Mass spectrometry for neurobiomarker discovery: the relevance of post-translational modifications. Cells 11:1279. https:\/\/doi.org\/10.3390\/cells11081279","journal-title":"Cells"},{"key":"7505_CR194","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev-biochem-061308-093216","volume":"80","author":"J Cox","year":"2011","unstructured":"Cox J, Mann M (2011) Quantitative, high-resolution proteomics for data-driven systems biology. Annu Rev Biochem 80:273\u2013299. https:\/\/doi.org\/10.1146\/annurev-biochem-061308-093216","journal-title":"Annu Rev Biochem"},{"key":"7505_CR195","doi-asserted-by":"publisher","first-page":"7192","DOI":"10.1039\/D2CC00200K","volume":"58","author":"A Tsirkou","year":"2022","unstructured":"Tsirkou A, Kaczorowski F, Verdurand M et al (2022) Charge detection mass spectrometry on human-amplified fibrils from different synucleinopathies. Chem Commun 58:7192\u20137195. https:\/\/doi.org\/10.1039\/D2CC00200K","journal-title":"Chem Commun"},{"key":"7505_CR196","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1039\/D4AN00634H","volume":"149","author":"L Zhang","year":"2024","unstructured":"Zhang L, Illes-Toth E, Cryar A et al (2024) A candidate reference measurement procedure for the quantification of \u03b1-synuclein in cerebrospinal fluid using an SI traceable primary calibrator and multiple reaction monitoring. Analyst 149:4842\u20134850. https:\/\/doi.org\/10.1039\/D4AN00634H","journal-title":"Analyst"},{"key":"7505_CR197","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1021\/acscentsci.0c01028","volume":"7","author":"E Sinclair","year":"2021","unstructured":"Sinclair E, Walton-Doyle C, Sarkar D et al (2021) Validating differential volatilome profiles in Parkinson\u2019s disease. ACS Cent Sci 7:300\u2013306. https:\/\/doi.org\/10.1021\/acscentsci.0c01028","journal-title":"ACS Cent Sci"},{"key":"7505_CR198","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1021\/acschemneuro.2c00264","volume":"13","author":"M Xu","year":"2022","unstructured":"Xu M, Jin H, Wu Z et al (2022) Mass spectrometry-based analysis of serum N-glycosylation changes in patients with Parkinson\u2019s disease. ACS Chem Neurosci 13:1719\u20131726. https:\/\/doi.org\/10.1021\/acschemneuro.2c00264","journal-title":"ACS Chem Neurosci"},{"key":"7505_CR199","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1021\/acschemneuro.3c00404","volume":"14","author":"M Xu","year":"2023","unstructured":"Xu M, Jin H, Ge W et al (2023) Mass spectrometric analysis of urinary N-glycosylation changes in patients with Parkinson\u2019s disease. ACS Chem Neurosci 14:3507\u20133517. https:\/\/doi.org\/10.1021\/acschemneuro.3c00404","journal-title":"ACS Chem Neurosci"},{"key":"7505_CR200","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1021\/acs.jproteome.8b00982","volume":"18","author":"P Bhattacharjee","year":"2019","unstructured":"Bhattacharjee P, \u00d6hrfelt A, Lashley T et al (2019) Mass spectrometric analysis of Lewy body-enriched \u03b1-synuclein in Parkinson\u2019s disease. J Proteome Res 18:2109\u20132120. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00982","journal-title":"J Proteome Res"},{"key":"7505_CR201","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41467-021-21669-4","volume":"12","author":"E Sinclair","year":"2021","unstructured":"Sinclair E, Trivedi DK, Sarkar D et al (2021) Metabolomics of sebum reveals lipid dysregulation in Parkinson\u2019s disease. Nat Commun 12:1592. https:\/\/doi.org\/10.1038\/s41467-021-21669-4","journal-title":"Nat Commun"},{"key":"7505_CR202","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1039\/D0CS00115E","volume":"50","author":"L Gao","year":"2021","unstructured":"Gao L, Wang W, Wang X et al (2021) Fluorescent probes for bioimaging of potential biomarkers in Parkinson\u2019s disease. Chem Soc Rev 50:1219\u20131250. https:\/\/doi.org\/10.1039\/D0CS00115E","journal-title":"Chem Soc Rev"},{"key":"7505_CR203","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1039\/C9TB01012B","volume":"7","author":"M Xu","year":"2019","unstructured":"Xu M, Li R, Li X et al (2019) NIR fluorescent probes with good water-solubility for detection of amyloid beta aggregates in Alzheimer\u2019s disease. J Mater Chem B 7:5535\u20135540. https:\/\/doi.org\/10.1039\/C9TB01012B","journal-title":"J Mater Chem B"},{"key":"7505_CR204","doi-asserted-by":"publisher","first-page":"116195","DOI":"10.1016\/j.ejmech.2024.116195","volume":"267","author":"X Sun","year":"2024","unstructured":"Sun X, Jiang Q, Zhang Y et al (2024) Advances in fluorescent probe development for bioimaging of potential Parkinson\u2019s biomarkers. Eur J Med Chem 267:116195. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116195","journal-title":"Eur J Med Chem"},{"key":"7505_CR205","doi-asserted-by":"publisher","first-page":"10336","DOI":"10.1021\/acs.analchem.0c00379","volume":"92","author":"A Das","year":"2020","unstructured":"Das A, Dutta T, Gadhe L et al (2020) Biocompatible fluorescent probe for selective detection of amyloid fibrils. Anal Chem 92:10336\u201310341. https:\/\/doi.org\/10.1021\/acs.analchem.0c00379","journal-title":"Anal Chem"},{"key":"7505_CR206","doi-asserted-by":"publisher","first-page":"47009","DOI":"10.1021\/acsomega.2c06139","volume":"7","author":"L Bryan","year":"2022","unstructured":"Bryan L, Awasthi S, Li Y et al (2022) Site-specific c-terminal fluorescent labeling of Tau protein. ACS Omega 7:47009\u201347014. https:\/\/doi.org\/10.1021\/acsomega.2c06139","journal-title":"ACS Omega"},{"key":"7505_CR207","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1021\/acschemneuro.4c00097","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Awasthi S, Bryan L et al (2024) Fluorescence-based monitoring of early-stage aggregation of amyloid-\u03b2, amylin peptide, Tau, and \u03b1-synuclein proteins. ACS Chem Neurosci 15:3113\u20133123. https:\/\/doi.org\/10.1021\/acschemneuro.4c00097","journal-title":"ACS Chem Neurosci"},{"key":"7505_CR208","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12916-023-03031-1","volume":"21","author":"S Rastogi","year":"2023","unstructured":"Rastogi S, Rani K, Rai S et al (2023) Fluorescence-tagged salivary small extracellular vesicles as a nanotool in early diagnosis of Parkinson\u2019s disease. BMC Med 21:335. https:\/\/doi.org\/10.1186\/s12916-023-03031-1","journal-title":"BMC Med"},{"key":"7505_CR209","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41531-023-00458-4","volume":"9","author":"A Schaffrath","year":"2023","unstructured":"Schaffrath A, Schleyken S, Seger A et al (2023) Patients with isolated REM-sleep behavior disorder have elevated levels of alpha-synuclein aggregates in stool. NPJ Parkinsons Dis 9:14. https:\/\/doi.org\/10.1038\/s41531-023-00458-4","journal-title":"NPJ Parkinsons Dis"},{"key":"7505_CR210","doi-asserted-by":"publisher","unstructured":"Saedi Z, Masroor MJ, Jahangiri-Manesh A, et al (2024) A label-free sensor array based on carbon quantum dots for detection of \u03b1-synuclein oligomers in saliva. Anal Chem acs.analchem.4c00874. https:\/\/doi.org\/10.1021\/acs.analchem.4c00874","DOI":"10.1021\/acs.analchem.4c00874"},{"key":"7505_CR211","doi-asserted-by":"publisher","first-page":"17223","DOI":"10.1021\/acs.analchem.2c03926","volume":"94","author":"S Tang","year":"2022","unstructured":"Tang S, Wu X, Zhao P et al (2022) Ratiometric fluorescence capillary sensor-integrated molecular imprinting for simultaneous detection of two biological indicators of Parkinson\u2019s disease. Anal Chem 94:17223\u201317231. https:\/\/doi.org\/10.1021\/acs.analchem.2c03926","journal-title":"Anal Chem"},{"key":"7505_CR212","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cca.2021.03.009","volume":"518","author":"A Mobed","year":"2021","unstructured":"Mobed A, Razavi S, Ali A et al (2021) Biosensors in Parkinson\u2019s disease. Clin Chim Acta 518:51\u201358. https:\/\/doi.org\/10.1016\/j.cca.2021.03.009","journal-title":"Clin Chim Acta"},{"key":"7505_CR213","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11011-025-01564-3","volume":"40","author":"M Hassanzadeh-khanmiri","year":"2025","unstructured":"Hassanzadeh-khanmiri M, Moshari A, Kheradmand R et al (2025) Nanomedicine: a cost-effective and powerful platform for managing neurodegenerative diseases. Metab Brain Dis 40:142. https:\/\/doi.org\/10.1007\/s11011-025-01564-3","journal-title":"Metab Brain Dis"},{"key":"7505_CR214","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00044-024-03237-9","volume":"33","author":"V Alivirdiloo","year":"2024","unstructured":"Alivirdiloo V, Hajiabbasi M, Gargari MK et al (2024) Neuroprotective role of nobiletin against amyloid-\u03b2 (A\u03b2) aggregation in Parkinson and Alzheimer disease as neurodegenerative diseases of brain. Med Chem Res 33:1055\u20131063. https:\/\/doi.org\/10.1007\/s00044-024-03237-9","journal-title":"Med Chem Res"},{"key":"7505_CR215","doi-asserted-by":"publisher","first-page":"12325","DOI":"10.1021\/acsnano.3c01393","volume":"17","author":"S Awasthi","year":"2023","unstructured":"Awasthi S, Ying C, Li J, Mayer M (2023) Simultaneous determination of the size and shape of single \u03b1-synuclein oligomers in solution. ACS Nano 17:12325\u201312335. https:\/\/doi.org\/10.1021\/acsnano.3c01393","journal-title":"ACS Nano"},{"key":"7505_CR216","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1021\/acsnano.3c08623","volume":"18","author":"C Cao","year":"2024","unstructured":"Cao C, Magalh\u00e3es P, Krapp LF et al (2024) Deep learning-assisted single-molecule detection of protein post-translational modifications with a biological nanopore. ACS Nano 18:1504\u20131515. https:\/\/doi.org\/10.1021\/acsnano.3c08623","journal-title":"ACS Nano"},{"key":"7505_CR217","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.snb.2017.01.171","volume":"245","author":"K Sun","year":"2017","unstructured":"Sun K, Xia N, Zhao L et al (2017) Aptasensors for the selective detection of alpha-synuclein oligomer by colorimetry, surface plasmon resonance and electrochemical impedance spectroscopy. Sens Actuators, B Chem 245:87\u201394. https:\/\/doi.org\/10.1016\/j.snb.2017.01.171","journal-title":"Sens Actuators, B Chem"},{"key":"7505_CR218","doi-asserted-by":"publisher","first-page":"704963","DOI":"10.3389\/fnins.2021.704963","volume":"15","author":"C Carlomagno","year":"2021","unstructured":"Carlomagno C, Bertazioli D, Gualerzi A et al (2021) Identification of the raman salivary fingerprint of Parkinson\u2019s disease through the spectroscopic\u2013 computational combinatory approach. Front Neurosci 15:704963. https:\/\/doi.org\/10.3389\/fnins.2021.704963","journal-title":"Front Neurosci"},{"key":"7505_CR219","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1109\/LSENS.2024.3413575","volume":"8","author":"RS Massey","year":"2024","unstructured":"Massey RS, Johri S, Chan D et al (2024) Comparison of aptamer and antibody bioreceptors in the OEGFET biosensor platform for detecting \u03b1-synuclein, a Parkinson\u2019s biomarker. IEEE Sens Lett 8:1\u20134. https:\/\/doi.org\/10.1109\/LSENS.2024.3413575","journal-title":"IEEE Sens Lett"},{"key":"7505_CR220","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1021\/acschemneuro.4c00106","volume":"15","author":"JM Balsamo","year":"2024","unstructured":"Balsamo JM, Zhou K, Kammarchedu V et al (2024) Mechanistic insight into intestinal \u03b1-synuclein aggregation in Parkinson\u2019s disease using a laser-printed electrochemical sensor. ACS Chem Neurosci 15:2623\u20132632. https:\/\/doi.org\/10.1021\/acschemneuro.4c00106","journal-title":"ACS Chem Neurosci"},{"key":"7505_CR221","doi-asserted-by":"publisher","first-page":"340890","DOI":"10.1016\/j.aca.2023.340890","volume":"1247","author":"S Ge","year":"2023","unstructured":"Ge S, Chen G, Deng J et al (2023) Multiplex signal amplification strategy-based early-stage diagnosis of Parkinson\u2019s disease on a SERS-enabled LoC system. Anal Chim Acta 1247:340890. https:\/\/doi.org\/10.1016\/j.aca.2023.340890","journal-title":"Anal Chim Acta"},{"key":"7505_CR222","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1039\/D1SM00298H","volume":"17","author":"X Yang","year":"2021","unstructured":"Yang X, Zhao X, Liu F et al (2021) Simple, rapid and sensitive detection of Parkinson\u2019s disease related alpha-synuclein using a DNA aptamer assisted liquid crystal biosensor. Soft Matter 17:4842\u20134847. https:\/\/doi.org\/10.1039\/D1SM00298H","journal-title":"Soft Matter"},{"key":"7505_CR223","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1021\/acssensors.3c02167","volume":"9","author":"Z Jia","year":"2024","unstructured":"Jia Z, Maghaydah Y, Zdanys K et al (2024) CRISPR-powered aptasensor for diagnostics of Alzheimer\u2019s disease. ACS Sens 9:398\u2013405. https:\/\/doi.org\/10.1021\/acssensors.3c02167","journal-title":"ACS Sens"},{"key":"7505_CR224","doi-asserted-by":"publisher","first-page":"1900244","DOI":"10.1002\/adhm.201900244","volume":"8","author":"N Jiang","year":"2019","unstructured":"Jiang N, Ahmed R, Damayantharan M et al (2019) Lateral and vertical flow assays for point-of-care diagnostics. Adv Healthc Mater 8:1900244. https:\/\/doi.org\/10.1002\/adhm.201900244","journal-title":"Adv Healthc Mater"},{"key":"7505_CR225","doi-asserted-by":"publisher","first-page":"157a","DOI":"10.1016\/j.bpj.2019.11.971","volume":"118","author":"J Li","year":"2020","unstructured":"Li J, Ying C, Awasthi S et al (2020) Protein trapping in a nanopore well. Biophys J 118:157a. https:\/\/doi.org\/10.1016\/j.bpj.2019.11.971","journal-title":"Biophys J"},{"key":"7505_CR226","doi-asserted-by":"publisher","first-page":"20776","DOI":"10.1038\/srep20776","volume":"6","author":"R Hu","year":"2016","unstructured":"Hu R, Diao J, Li J et al (2016) Intrinsic and membrane-facilitated \u03b1-synuclein oligomerization revealed by label-free detection through solid-state nanopores. Sci Rep 6:20776. https:\/\/doi.org\/10.1038\/srep20776","journal-title":"Sci Rep"},{"key":"7505_CR227","doi-asserted-by":"publisher","first-page":"2000177","DOI":"10.1002\/smtd.202000177","volume":"4","author":"S Awasthi","year":"2020","unstructured":"Awasthi S, Sriboonpeng P, Ying C et al (2020) Polymer coatings to minimize protein adsorption in solid-state nanopores. Small Methods 4:2000177. https:\/\/doi.org\/10.1002\/smtd.202000177","journal-title":"Small Methods"},{"key":"7505_CR228","doi-asserted-by":"publisher","first-page":"25776","DOI":"10.1021\/jacs.3c09335","volume":"145","author":"SE Sandler","year":"2023","unstructured":"Sandler SE, Horne RI, Rocchetti S et al (2023) Multiplexed digital characterization of misfolded protein oligomers via solid-state nanopores. J Am Chem Soc 145:25776\u201325788. https:\/\/doi.org\/10.1021\/jacs.3c09335","journal-title":"J Am Chem Soc"},{"key":"7505_CR229","doi-asserted-by":"publisher","first-page":"22999","DOI":"10.1021\/acsnano.3c08456","volume":"17","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang X, Campolo G et al (2023) Single-molecule detection of \u03b1-synuclein oligomers in Parkinson\u2019s disease patients using nanopores. ACS Nano 17:22999\u201323009. https:\/\/doi.org\/10.1021\/acsnano.3c08456","journal-title":"ACS Nano"},{"key":"7505_CR230","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/s41467-017-01584-3","volume":"8","author":"JYY Sze","year":"2017","unstructured":"Sze JYY, Ivanov AP, Cass AEG, Edel JB (2017) Single molecule multiplexed nanopore protein screening in human serum using aptamer modified DNA carriers. Nat Commun 8:1552. https:\/\/doi.org\/10.1038\/s41467-017-01584-3","journal-title":"Nat Commun"},{"key":"7505_CR231","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41578-020-0229-6","volume":"5","author":"L Xue","year":"2020","unstructured":"Xue L, Yamazaki H, Ren R et al (2020) Solid-state nanopore sensors. Nat Rev Mater 5:931\u2013951. https:\/\/doi.org\/10.1038\/s41578-020-0229-6","journal-title":"Nat Rev Mater"},{"key":"7505_CR232","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1021\/acscentsci.1c01404","volume":"8","author":"N Meyer","year":"2022","unstructured":"Meyer N, Janot J-M, Torrent J, Balme S (2022) Real-time fast amyloid seeding and translocation of \u03b1-synuclein with a nanopipette. ACS Cent Sci 8:441\u2013448. https:\/\/doi.org\/10.1021\/acscentsci.1c01404","journal-title":"ACS Cent Sci"},{"key":"7505_CR233","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s44328-024-00003-0","volume":"1","author":"PR Christenson","year":"2024","unstructured":"Christenson PR, Jeong H, Ahn H et al (2024) Visual detection of misfolded alpha-synuclein and prions via capillary-based quaking-induced conversion assay (Cap-QuIC). NPJ Biosens 1:2. https:\/\/doi.org\/10.1038\/s44328-024-00003-0","journal-title":"NPJ Biosens"},{"key":"7505_CR234","doi-asserted-by":"publisher","first-page":"127163","DOI":"10.1016\/j.foodchem.2020.127163","volume":"331","author":"M Mansouri","year":"2020","unstructured":"Mansouri M, Fathi F, Jalili R et al (2020) SPR enhanced DNA biosensor for sensitive detection of donkey meat adulteration. Food Chem 331:127163. https:\/\/doi.org\/10.1016\/j.foodchem.2020.127163","journal-title":"Food Chem"},{"key":"7505_CR235","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1016\/S1452-3981(23)18318-0","volume":"6","author":"B Khalilzadeh","year":"2011","unstructured":"Khalilzadeh B, Hasanzadeh M, Sanati S et al (2011) Preparation of a new electrochemical sensor based on cadmium oxide nanoparticles and application for determination of penicillamine. Int J Electrochem Sci 6:4164\u20134175. https:\/\/doi.org\/10.1016\/S1452-3981(23)18318-0","journal-title":"Int J Electrochem Sci"},{"key":"7505_CR236","doi-asserted-by":"publisher","first-page":"120700","DOI":"10.1016\/j.talanta.2019.120700","volume":"211","author":"P Carneiro","year":"2020","unstructured":"Carneiro P, Morais S, Do Carmo Pereira M (2020) Biosensors on the road to early diagnostic and surveillance of Alzheimer\u2019s disease. Talanta 211:120700. https:\/\/doi.org\/10.1016\/j.talanta.2019.120700","journal-title":"Talanta"},{"key":"7505_CR237","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ab.2016.11.012","volume":"518","author":"D Gelinsky-Wersing","year":"2017","unstructured":"Gelinsky-Wersing D, Wersing W, Pompe W (2017) Bivalent kinetic binding model to surface plasmon resonance studies of antigen-antibody displacement reactions. Anal Biochem 518:110\u2013125. https:\/\/doi.org\/10.1016\/j.ab.2016.11.012","journal-title":"Anal Biochem"},{"key":"7505_CR238","doi-asserted-by":"publisher","first-page":"128146","DOI":"10.1016\/j.snb.2020.128146","volume":"316","author":"T \u0160pringer","year":"2020","unstructured":"\u0160pringer T, Hemmerov\u00e1 E, Finocchiaro G et al (2020) Surface plasmon resonance biosensor for the detection of tau-amyloid \u03b2 complex. Sens Actuators, B Chem 316:128146. https:\/\/doi.org\/10.1016\/j.snb.2020.128146","journal-title":"Sens Actuators, B Chem"},{"key":"7505_CR239","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1021\/am507972b","volume":"7","author":"XR Cheng","year":"2015","unstructured":"Cheng XR, Wallace GQ, Lagugn\u00e9-Labarthet F, Kerman K (2015) Au nanostructured surfaces for electrochemical and localized surface plasmon resonance-based monitoring of \u03b1-synuclein\u2013small molecule interactions. ACS Appl Mater Interfaces 7:4081\u20134088. https:\/\/doi.org\/10.1021\/am507972b","journal-title":"ACS Appl Mater Interfaces"},{"key":"7505_CR240","doi-asserted-by":"publisher","unstructured":"Apayd\u0131n BB, \u00c7amo\u011flu T, Canbek \u00d6zdil ZC, et al (2024) Chitosan\u2010enhanced sensitivity of mercaptoundecanoic acid (MUA)\u2010 capped gold nanorod based localized surface plasmon resonance (LSPR) biosensor for detection of alpha\u2010synuclein oligomer biomarker in Parkinson\u2019s disease. Biotech and App Biochem bab.2653. https:\/\/doi.org\/10.1002\/bab.2653","DOI":"10.1002\/bab.2653"},{"key":"7505_CR241","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.snb.2017.08.051","volume":"255","author":"A Khatri","year":"2018","unstructured":"Khatri A, Punjabi N, Ghosh D et al (2018) Detection and differentiation of \u03b1-synuclein monomer and fibril by chitosan film coated nanogold array on optical sensor platform. Sens Actuators, B Chem 255:692\u2013700. https:\/\/doi.org\/10.1016\/j.snb.2017.08.051","journal-title":"Sens Actuators, B Chem"},{"key":"7505_CR242","doi-asserted-by":"publisher","first-page":"342559","DOI":"10.1016\/j.aca.2024.342559","volume":"1304","author":"JF Giarola","year":"2024","unstructured":"Giarola JF, Santos J, Estevez M-C et al (2024) An \u03b1-helical peptide-based plasmonic biosensor for highly specific detection of \u03b1-synuclein toxic oligomers. Anal Chim Acta 1304:342559. https:\/\/doi.org\/10.1016\/j.aca.2024.342559","journal-title":"Anal Chim Acta"},{"key":"7505_CR243","doi-asserted-by":"publisher","first-page":"112511","DOI":"10.1016\/j.bios.2020.112511","volume":"167","author":"A Rezabakhsh","year":"2020","unstructured":"Rezabakhsh A, Rahbarghazi R, Fathi F (2020) Surface plasmon resonance biosensors for detection of Alzheimer\u2019s biomarkers; an effective step in early and accurate diagnosis. Biosens Bioelectron 167:112511. https:\/\/doi.org\/10.1016\/j.bios.2020.112511","journal-title":"Biosens Bioelectron"},{"key":"7505_CR244","doi-asserted-by":"publisher","first-page":"27845","DOI":"10.1021\/acsami.1c04833","volume":"13","author":"J Lee","year":"2021","unstructured":"Lee J, Lee K, Lim CT (2021) Surface plasmon resonance assay for identification of small molecules capable of inhibiting A\u03b2 aggregation. ACS Appl Mater Interfaces 13:27845\u201327855. https:\/\/doi.org\/10.1021\/acsami.1c04833","journal-title":"ACS Appl Mater Interfaces"},{"key":"7505_CR245","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1007\/s00259-024-06806-7","volume":"51","author":"J Sobek","year":"2024","unstructured":"Sobek J, Li J, Combes BF et al (2024) Efficient characterization of multiple binding sites of small molecule imaging ligands on amyloid-beta, tau and alpha-synuclein. Eur J Nucl Med Mol Imaging 51:3960\u20133977. https:\/\/doi.org\/10.1007\/s00259-024-06806-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7505_CR246","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.3390\/s100301871","volume":"10","author":"A Downes","year":"2010","unstructured":"Downes A, Elfick A (2010) Raman spectroscopy and related techniques in biomedicine. Sensors (Basel) 10:1871\u20131889. https:\/\/doi.org\/10.3390\/s100301871","journal-title":"Sensors (Basel)"},{"key":"7505_CR247","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1021\/acschemneuro.7b00413","volume":"9","author":"G Devitt","year":"2018","unstructured":"Devitt G, Howard K, Mudher A, Mahajan S (2018) Raman spectroscopy: an emerging tool in neurodegenerative disease research and diagnosis. ACS Chem Neurosci 9:404\u2013420. https:\/\/doi.org\/10.1021\/acschemneuro.7b00413","journal-title":"ACS Chem Neurosci"},{"key":"7505_CR248","doi-asserted-by":"publisher","first-page":"102097","DOI":"10.1016\/j.nano.2019.102097","volume":"22","author":"A Gualerzi","year":"2019","unstructured":"Gualerzi A, Picciolini S, Carlomagno C et al (2019) Raman profiling of circulating extracellular vesicles for the stratification of Parkinson\u2019s patients. Nanomedicine Nanotechnol Biol Med 22:102097. https:\/\/doi.org\/10.1016\/j.nano.2019.102097","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"issue":"1","key":"7505_CR249","doi-asserted-by":"publisher","first-page":"10175","DOI":"10.1038\/s41598-020-67138-8","volume":"10","author":"C Carlomagno","year":"2020","unstructured":"Carlomagno C, Banfi PI, Gualerzi A et al (2020) Human salivary raman fingerprint as biomarker for the diagnosis of amyotrophic lateral sclerosis. Sci Rep 10(1):10175. https:\/\/doi.org\/10.1038\/s41598-020-67138-8","journal-title":"Sci Rep"},{"key":"7505_CR250","doi-asserted-by":"publisher","first-page":"21830","DOI":"10.1021\/acsami.3c00103","volume":"15","author":"X Cao","year":"2023","unstructured":"Cao X, Ge S, Chen M et al (2023) LoC-SERS platform integrated with the signal amplification strategy toward Parkinson\u2019s disease diagnosis. ACS Appl Mater Interfaces 15:21830\u201321842. https:\/\/doi.org\/10.1021\/acsami.3c00103","journal-title":"ACS Appl Mater Interfaces"},{"key":"7505_CR251","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1039\/D3AN00027C","volume":"148","author":"I Badillo-Ram\u00edrez","year":"2023","unstructured":"Badillo-Ram\u00edrez I, Landeros-Rivera B, Saniger JM et al (2023) SERS-based detection of 5- S -cysteinyl-dopamine as a novel biomarker of Parkinson\u2019s disease in artificial biofluids. Analyst 148:1848\u20131857. https:\/\/doi.org\/10.1039\/D3AN00027C","journal-title":"Analyst"},{"key":"7505_CR252","doi-asserted-by":"publisher","first-page":"e1701247","DOI":"10.1126\/sciadv.1701247","volume":"3","author":"W Fu","year":"2017","unstructured":"Fu W, Feng L, Panaitov G et al (2017) Biosensing near the neutrality point of graphene. Sci Adv 3:e1701247. https:\/\/doi.org\/10.1126\/sciadv.1701247","journal-title":"Sci Adv"},{"key":"7505_CR253","doi-asserted-by":"publisher","first-page":"112505","DOI":"10.1016\/j.bios.2020.112505","volume":"167","author":"D Park","year":"2020","unstructured":"Park D, Kim JH, Kim HJ et al (2020) Multiplexed femtomolar detection of Alzheimer\u2019s disease biomarkers in biofluids using a reduced graphene oxide field-effect transistor. Biosens Bioelectron 167:112505. https:\/\/doi.org\/10.1016\/j.bios.2020.112505","journal-title":"Biosens Bioelectron"},{"key":"7505_CR254","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1021\/acssensors.3c00757","volume":"8","author":"RS Massey","year":"2023","unstructured":"Massey RS, McConnell EM, Chan D et al (2023) Non-invasive monitoring of \u03b1-synuclein in saliva for Parkinson\u2019s disease using organic electrolyte-gated FET aptasensor. ACS Sens 8:3116\u20133126. https:\/\/doi.org\/10.1021\/acssensors.3c00757","journal-title":"ACS Sens"},{"key":"7505_CR255","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1038\/s41598-020-60715-x","volume":"10","author":"SJ Park","year":"2020","unstructured":"Park SJ, Lee J, Seo SE et al (2020) High-performance conducting polymer nanotube-based liquid-ion gated field-effect transistor aptasensor for dopamine exocytosis. Sci Rep 10:3772. https:\/\/doi.org\/10.1038\/s41598-020-60715-x","journal-title":"Sci Rep"},{"key":"7505_CR256","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1021\/acssensors.2c00967","volume":"7","author":"H Chen","year":"2022","unstructured":"Chen H, Xiao M, He J et al (2022) Aptamer-functionalized carbon nanotube field-effect transistor biosensors for Alzheimer\u2019s disease serum biomarker detection. ACS Sens 7:2075\u20132083. https:\/\/doi.org\/10.1021\/acssensors.2c00967","journal-title":"ACS Sens"},{"key":"7505_CR257","doi-asserted-by":"publisher","first-page":"7960","DOI":"10.1039\/D4CS00001C","volume":"53","author":"C Ye","year":"2024","unstructured":"Ye C, Lukas H, Wang M et al (2024) Nucleic acid-based wearable and implantable electrochemical sensors. Chem Soc Rev 53:7960\u20137982. https:\/\/doi.org\/10.1039\/D4CS00001C","journal-title":"Chem Soc Rev"},{"key":"7505_CR258","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ijbiomac.2019.05.061","volume":"134","author":"B Khalilzadeh","year":"2019","unstructured":"Khalilzadeh B, Rashidi M, Soleimanian A et al (2019) Development of a reliable microRNA based electrochemical genosensor for monitoring of miR-146a, as key regulatory agent of neurodegenerative disease. Int J Biol Macromol 134:695\u2013703. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.05.061","journal-title":"Int J Biol Macromol"},{"key":"7505_CR259","doi-asserted-by":"publisher","first-page":"127821","DOI":"10.1016\/j.snb.2020.127821","volume":"309","author":"C Guo","year":"2020","unstructured":"Guo C, Hu M, Li Z et al (2020) Structural hybridization of bimetallic zeolitic imidazolate framework (ZIF) nanosheets and carbon nanofibers for efficiently sensing \u03b1-synuclein oligomers. Sens Actuators, B Chem 309:127821. https:\/\/doi.org\/10.1016\/j.snb.2020.127821","journal-title":"Sens Actuators, B Chem"},{"key":"7505_CR260","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/28378083.2024.2386517","volume":"1","author":"B \u0130nce","year":"2024","unstructured":"\u0130nce B, Kavac\u0131k M, Sezgint\u00fcrk MK (2024) Electrochemical aptamer-based biosensors for disease biomarkers. Essential Chem 1:1\u201323. https:\/\/doi.org\/10.1080\/28378083.2024.2386517","journal-title":"Essential Chem"},{"key":"7505_CR261","doi-asserted-by":"publisher","first-page":"112016","DOI":"10.1016\/j.bios.2020.112016","volume":"152","author":"GCMD Oliveira","year":"2020","unstructured":"Oliveira GCMD, Carvalho JHDS, Brazaca LC et al (2020) Flexible platinum electrodes as electrochemical sensor and immunosensor for Parkinson\u2019s disease biomarkers. Biosens Bioelectron 152:112016. https:\/\/doi.org\/10.1016\/j.bios.2020.112016","journal-title":"Biosens Bioelectron"},{"key":"7505_CR262","doi-asserted-by":"publisher","first-page":"161329","DOI":"10.1016\/j.cej.2025.161329","volume":"509","author":"S Jeong","year":"2025","unstructured":"Jeong S, Park S-H, Lee S et al (2025) Electrochemical biosensor based on gold nanoparticles\/laser induced graphene for diagnosis of Parkinson\u2019s disease by detecting phosphorylated \u03b1-synuclein in human blood. Chem Eng J 509:161329. https:\/\/doi.org\/10.1016\/j.cej.2025.161329","journal-title":"Chem Eng J"},{"key":"7505_CR263","doi-asserted-by":"publisher","first-page":"126907","DOI":"10.1016\/j.jhazmat.2021.126907","volume":"422","author":"A Aziz","year":"2022","unstructured":"Aziz A, Asif M, Ashraf G et al (2022) Boosting electrocatalytic activity of carbon fiber@fusiform-like copper-nickel LDHs: sensing of nitrate as biomarker for NOB detection. J Hazard Mater 422:126907. https:\/\/doi.org\/10.1016\/j.jhazmat.2021.126907","journal-title":"J Hazard Mater"},{"key":"7505_CR264","doi-asserted-by":"publisher","first-page":"114301","DOI":"10.1016\/j.bios.2022.114301","volume":"210","author":"H Dong","year":"2022","unstructured":"Dong H, Zhao L, Zhu X et al (2022) Development of a novel ratiometric electrochemical sensor for monitoring \u03b2-galactosidase in Parkinson\u2019s disease model mice. Biosens Bioelectron 210:114301. https:\/\/doi.org\/10.1016\/j.bios.2022.114301","journal-title":"Biosens Bioelectron"},{"key":"7505_CR265","doi-asserted-by":"publisher","first-page":"19480","DOI":"10.1021\/acsami.2c02119","volume":"14","author":"M Asif","year":"2022","unstructured":"Asif M, Ashraf G, Aziz A et al (2022) Tuning the redox chemistry of copper oxide nanoarchitectures integrated with rGOP via facet engineering: sensing H2 S toward SRB detection. ACS Appl Mater Interfaces 14:19480\u201319490. https:\/\/doi.org\/10.1021\/acsami.2c02119","journal-title":"ACS Appl Mater Interfaces"},{"key":"7505_CR266","doi-asserted-by":"publisher","first-page":"135985","DOI":"10.1016\/j.cej.2022.135985","volume":"440","author":"A Aziz","year":"2022","unstructured":"Aziz A, Asif M, Ashraf G et al (2022) Showcasing advanced electrocatalytic behavior of layered double hydroxide wrapped on carbon nanotubes: real-time monitoring of L-cysteine in biological matrices. Chem Eng J 440:135985. https:\/\/doi.org\/10.1016\/j.cej.2022.135985","journal-title":"Chem Eng J"},{"key":"7505_CR267","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.aca.2019.10.012","volume":"1094","author":"R Zhang","year":"2020","unstructured":"Zhang R, Wang S, Huang X et al (2020) Gold-nanourchin seeded single-walled carbon nanotube on voltammetry sensor for diagnosing neurogenerative Parkinson\u2019s disease. Anal Chim Acta 1094:142\u2013150. https:\/\/doi.org\/10.1016\/j.aca.2019.10.012","journal-title":"Anal Chim Acta"},{"key":"7505_CR268","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1039\/D0AN00169D","volume":"145","author":"Q Wu","year":"2020","unstructured":"Wu Q, Tan R, Mi X, Tu Y (2020) Electrochemiluminescent aptamer-sensor for alpha synuclein oligomer based on a metal\u2013organic framework. Analyst 145:2159\u20132167. https:\/\/doi.org\/10.1039\/D0AN00169D","journal-title":"Analyst"},{"key":"7505_CR269","doi-asserted-by":"publisher","first-page":"32075","DOI":"10.1021\/acsami.3c02004","volume":"15","author":"M Asif","year":"2023","unstructured":"Asif M, Wang Z, Aziz A et al (2023) Hybridizing Ti3 C2 T x layers with layered double hydroxide nanosheets at the molecular level: a smart electrode material for H2 O2 monitoring in cancer cells. ACS Appl Mater Interfaces 15:32075\u201332086. https:\/\/doi.org\/10.1021\/acsami.3c02004","journal-title":"ACS Appl Mater Interfaces"},{"key":"7505_CR270","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bios.2018.09.081","volume":"123","author":"SM Taghdisi","year":"2019","unstructured":"Taghdisi SM, Danesh NM, Nameghi MA et al (2019) A novel electrochemical aptasensor based on nontarget-induced high accumulation of methylene blue on the surface of electrode for sensing of \u03b1-synuclein oligomer. Biosens Bioelectron 123:14\u201318. https:\/\/doi.org\/10.1016\/j.bios.2018.09.081","journal-title":"Biosens Bioelectron"},{"key":"7505_CR271","doi-asserted-by":"publisher","first-page":"131398","DOI":"10.1016\/j.cej.2021.131398","volume":"427","author":"M Asif","year":"2022","unstructured":"Asif M, Aziz A, Ashraf G et al (2022) Unveiling microbiologically influenced corrosion engineering to transfigure damages into benefits: a textile sensor for H2O2 detection in clinical cancer tissues. Chem Eng J 427:131398. https:\/\/doi.org\/10.1016\/j.cej.2021.131398","journal-title":"Chem Eng J"},{"key":"7505_CR272","doi-asserted-by":"publisher","first-page":"e00263","DOI":"10.1016\/j.teac.2025.e00263","volume":"46","author":"M Asif","year":"2025","unstructured":"Asif M, Algethami JS, Alhamami MAM et al (2025) Redefining nanobiosensors in rapid detection of viral infections: where are we now? Trends Environ Anal Chem 46:e00263. https:\/\/doi.org\/10.1016\/j.teac.2025.e00263","journal-title":"Trends Environ Anal Chem"},{"key":"7505_CR273","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1021\/acsnano.0c10035","volume":"15","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhan L, Qin Z et al (2021) Ultrasensitive and highly specific lateral flow assays for point-of-care diagnosis. ACS Nano 15:3593\u20133611. https:\/\/doi.org\/10.1021\/acsnano.0c10035","journal-title":"ACS Nano"},{"key":"7505_CR274","doi-asserted-by":"publisher","first-page":"112278","DOI":"10.1016\/j.bios.2020.112278","volume":"165","author":"M Chen","year":"2020","unstructured":"Chen M, Li H, Shi Z et al (2020) High fluorescence quenching probe-based reverse fluorescence enhancement LFTS coupling with IS-primer amplification reaction for the rapid and sensitive Parkinson disease-associated microRNA detection. Biosens Bioelectron 165:112278. https:\/\/doi.org\/10.1016\/j.bios.2020.112278","journal-title":"Biosens Bioelectron"},{"key":"7505_CR275","doi-asserted-by":"publisher","first-page":"113637","DOI":"10.1016\/j.ab.2020.113637","volume":"596","author":"S Dalirirad","year":"2020","unstructured":"Dalirirad S, Steckl AJ (2020) Lateral flow assay using aptamer-based sensing for on-site detection of dopamine in urine. Anal Biochem 596:113637. https:\/\/doi.org\/10.1016\/j.ab.2020.113637","journal-title":"Anal Biochem"},{"key":"7505_CR276","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12951-021-01111-z","volume":"19","author":"L Zhang","year":"2021","unstructured":"Zhang L, Du X, Su Y et al (2021) Quantitative assessment of AD markers using naked eyes: point-of-care testing with paper-based lateral flow immunoassay. J Nanobiotechnol 19:366. https:\/\/doi.org\/10.1186\/s12951-021-01111-z","journal-title":"J Nanobiotechnol"},{"key":"7505_CR277","doi-asserted-by":"publisher","first-page":"115840","DOI":"10.1016\/j.bios.2023.115840","volume":"245","author":"X Liu","year":"2024","unstructured":"Liu X, Su X, Chen M et al (2024) Self-calibrating surface-enhanced raman scattering-lateral flow immunoassay for determination of amyloid-\u03b2 biomarker of Alzheimer\u2019s disease. Biosens Bioelectron 245:115840. https:\/\/doi.org\/10.1016\/j.bios.2023.115840","journal-title":"Biosens Bioelectron"},{"key":"7505_CR278","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","volume":"6","author":"BR Groveman","year":"2018","unstructured":"Groveman BR, Orr\u00f9 CD, Hughson AG et al (2018) Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1syn RT-QuIC. Acta Neuropathol Commun 6:7. https:\/\/doi.org\/10.1186\/s40478-018-0508-2","journal-title":"Acta Neuropathol Commun"},{"key":"7505_CR279","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41565-021-01045-5","volume":"17","author":"H Altug","year":"2022","unstructured":"Altug H, Oh S-H, Maier SA, Homola J (2022) Advances and applications of nanophotonic biosensors. Nat Nanotechnol 17:5\u201316. https:\/\/doi.org\/10.1038\/s41565-021-01045-5","journal-title":"Nat Nanotechnol"},{"key":"7505_CR280","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3390\/electronics12040783","volume":"12","author":"S Dixit","year":"2023","unstructured":"Dixit S, Bohre K, Singh Y et al (2023) A comprehensive review on AI-enabled models for Parkinson\u2019s disease diagnosis. Electronics 12:783. https:\/\/doi.org\/10.3390\/electronics12040783","journal-title":"Electronics"},{"key":"7505_CR281","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1049\/iet-ipr.2020.1048","volume":"14","author":"H Khachnaoui","year":"2020","unstructured":"Khachnaoui H, Mabrouk R, Khlifa N (2020) Machine learning and deep learning for clinical data and PET\/SPECT imaging in Parkinson\u2019s disease: a review. IET Image Process 14:4013\u20134026. https:\/\/doi.org\/10.1049\/iet-ipr.2020.1048","journal-title":"IET Image Process"},{"key":"7505_CR282","doi-asserted-by":"publisher","first-page":"69393","DOI":"10.1007\/s11042-024-18186-z","volume":"83","author":"PK Keserwani","year":"2024","unstructured":"Keserwani PK, Das S, Sarkar N (2024) A comparative study: prediction of Parkinson\u2019s disease using machine learning, deep learning and nature inspired algorithm. Multimed Tools Appl 83:69393\u201369441. https:\/\/doi.org\/10.1007\/s11042-024-18186-z","journal-title":"Multimed Tools Appl"},{"key":"7505_CR283","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1039\/B922628C","volume":"40","author":"SL Pimlott","year":"2011","unstructured":"Pimlott SL, Sutherland A (2011) Molecular tracers for the PET and SPECT imaging of disease. Chem Soc Rev 40:149\u2013162. https:\/\/doi.org\/10.1039\/B922628C","journal-title":"Chem Soc Rev"},{"key":"7505_CR284","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"K Marek","year":"2011","unstructured":"Marek K, Jennings D, Lasch S et al (2011) The Parkinson progression marker initiative (PPMI). Prog Neurobiol 95:629\u2013635. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.09.005","journal-title":"Prog Neurobiol"},{"key":"7505_CR285","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/bios14070356","volume":"14","author":"T Wasilewski","year":"2024","unstructured":"Wasilewski T, Kamysz W, G\u0119bicki J (2024) Ai-assisted detection of biomarkers by sensors and biosensors for early diagnosis and monitoring. Biosensors 14:356. https:\/\/doi.org\/10.3390\/bios14070356","journal-title":"Biosensors"},{"key":"7505_CR286","doi-asserted-by":"publisher","first-page":"1084001","DOI":"10.3389\/frai.2023.1084001","volume":"6","author":"R Alshammri","year":"2023","unstructured":"Alshammri R, Alharbi G, Alharbi E, Almubark I (2023) Machine learning approaches to identify Parkinson\u2019s disease using voice signal features. Front Artif Intell 6:1084001. https:\/\/doi.org\/10.3389\/frai.2023.1084001","journal-title":"Front Artif Intell"},{"key":"7505_CR287","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.eswa.2018.06.003","volume":"110","author":"L Parisi","year":"2018","unstructured":"Parisi L, RaviChandran N, Manaog ML (2018) Feature-driven machine learning to improve early diagnosis of Parkinson\u2019s disease. Expert Syst Appl 110:182\u2013190. https:\/\/doi.org\/10.1016\/j.eswa.2018.06.003","journal-title":"Expert Syst Appl"},{"key":"7505_CR288","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.3390\/diagnostics12112708","volume":"12","author":"A Rana","year":"2022","unstructured":"Rana A, Dumka A, Singh R et al (2022) A computerized analysis with machine learning techniques for the diagnosis of Parkinson\u2019s disease: past studies and future perspectives. Diagnostics 12:2708. https:\/\/doi.org\/10.3390\/diagnostics12112708","journal-title":"Diagnostics"},{"key":"7505_CR289","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.3390\/ijerph17072594","volume":"17","author":"H Byeon","year":"2020","unstructured":"Byeon H (2020) Is the random forest algorithm suitable for predicting Parkinson\u2019s disease with mild cognitive impairment out of Parkinson\u2019s disease with normal cognition? IJERPH 17:2594. https:\/\/doi.org\/10.3390\/ijerph17072594","journal-title":"IJERPH"},{"key":"7505_CR290","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40708-020-00112-2","volume":"7","author":"MBT Noor","year":"2020","unstructured":"Noor MBT, Zenia NZ, Kaiser MS et al (2020) Application of deep learning in detecting neurological disorders from magnetic resonance images: a survey on the detection of Alzheimer\u2019s disease, Parkinson\u2019s disease and schizophrenia. Brain Inf 7:11. https:\/\/doi.org\/10.1186\/s40708-020-00112-2","journal-title":"Brain Inf"},{"key":"7505_CR291","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.11591\/eei.v10i5.3128","volume":"10","author":"HAAE Aal","year":"2021","unstructured":"Aal HAAE, Taie SA, El-Bendary N (2021) An optimized RNN-LSTM approach for Parkinson\u2019s disease early detection using speech features. Bulletin EEI 10:2503\u20132512. https:\/\/doi.org\/10.11591\/eei.v10i5.3128","journal-title":"Bulletin EEI"},{"key":"7505_CR292","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.3390\/s23042293","volume":"23","author":"G Costantini","year":"2023","unstructured":"Costantini G, Cesarini V, Di Leo P et al (2023) Artificial intelligence-based voice assessment of patients with Parkinson\u2019s disease off and on treatment: machine vs. deep-learning comparison. Sensors 23:2293. https:\/\/doi.org\/10.3390\/s23042293","journal-title":"Sensors"}],"container-title":["Microchimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00604-025-07505-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00604-025-07505-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00604-025-07505-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T14:17:45Z","timestamp":1760969865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00604-025-07505-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":292,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["7505"],"URL":"https:\/\/doi.org\/10.1007\/s00604-025-07505-2","relation":{},"ISSN":["0026-3672","1436-5073"],"issn-type":[{"value":"0026-3672","type":"print"},{"value":"1436-5073","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"691"}}